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ABSTRACT 
 
Synthesis of Heptakis-2-O-Sulfo-Cyclomaltoheptaose, a Single-Isomer Chiral Resolving 
Agent for Enantiomer Separations in Capillary Electrophoresis. 
 (December 2010) 
Edward Tutu, B.S., University of Cape Coast; M.S., University of Minnesota 
Chair of Advisory Committee: Dr. Gyula Vigh 
 
Single-isomer sulfated cyclodextrins (SISCDs) have proven to be reliable, 
effective, robust means for separation of enantiomers by capillary electrophoresis (CE). 
SISCD derivatives used as chiral resolving agents in CE can carry the sulfo groups either 
at the C2, C3 or C6 positions of the glucopyranose subunits which provides varied 
intermolecular interactions to bring about favorable enantioselectivities. 
The first single-isomer, sulfated β-CD that carries the sulfo group at the C2 
position, the sodium salt of heptakis(2-O-sulfo-3-O-methyl-6-O-
acetyl)cyclomaltoheptaose (HAMS) has been synthesized. The purity of each synthetic 
intermediate and of the final product was determined by HILIC and reversed phase 
HPLC. The structural identity of each intermediate and the final product was verified by 
1D, and 2D NMR, and MALDI-TOF mass spectrometry. 
HAMS has been used as chiral resolving agent for the CE separation of a set of 
nonionic, weak base and strong acid enantiomers in pH 2.5 background electrolytes. 
Rapid separations with satisfactory peak resolution values were obtained for the 
 iv
enantiomers of most of the nonionic and weak base analytes. Typically, low 
concentrations of HAMS were required to effect good enantiomer resolution. 
The trends in the effective mobilities and separation selectivities as a function of 
HAMS concentrations followed the predictions of the ionic strength-corrected charged 
resolving agent migration model (CHARM model). HAMS showed poor complexation 
with the anionic strong electrolyte enantiomers for which no peak resolution was 
observed. The separation patterns observed with HAMS as chiral resolving agent were 
compared with those of other β-cyclodextrin analogues, including heptakis(2-O-methyl-
3-O-acetyl-6-O-sulfo)-β-cyclodextrin (HMAS), heptakis(2-O-methyl-3,6-di-O-sulfo)-β-
cyclodextrin (HMdiSu), heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-cyclodextrin (HDAS) 
and heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin (HDMS).  
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NOMENCLATURE 
 
Ac2O  acetic anhydride 
CE  capillary electrophoresis 
DMF  N,N-dimethylformamide 
DMSO  dimethylsulfoxide 
EOF  electroosmotic flow 
EtOAc  ethylacetate 
EtOH  ethanol 
MeOH  methanol 
Py  pyridine 
Pyr.SO3 pyridine sulfur trioxide 
SISCD  single-isomer sulfated cyclodextrin 
TBAI  tetrabutylammonium iodide 
TBDMS tert-butyldimethylchlorosilane 
THF                 tetrahydrofuran 
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CHAPTER I  
INTRODUCTION 
 
1.1 Enantiomers and Separation Techniques 
It has been reported that among 523 natural and semi-synthetic drugs, 
approximately 99% are chiral and about 98% of them are sold as a single isomer. In the 
case of synthetic drugs, about 12% of them are sold as a single isomer.1 Enantiomers can 
have different biological or pharmacological activity. Thus one enantiomer may be the 
effective agent with a useful therapeutic value, while the other enantiomer might be 
inactive or active in a different way, contributing to side-effects, or be even toxic.2 These 
differences in the biological activity of enantiomers stem from their different mode of 
protein binding and transport, rate of metabolism as well as mechanism of action.3 
Therefore, the pharmacological effects and metabolic pathways for each enantiomer of a 
new chiral drug must be thoroughly studied before it is approved for human 
consumption.4 However, in order to study these properties effectively, a suitable method 
for separation of enanantiomers should be developed. 
Most common methods used in enantioseparation include gas chromatography 
(GC),5,6 high performance liquid chromatography (HPLC), including both normal and 
reversed  phase,7, 8, 9  ion-chromatography10  and  thin-layer  chromatography  (TLC),11,12   
____________ 
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supercritical fluid chromatography (SFC)13,14  and capillary electrophoresis (CE)15. 
Though the separation efficiency of capillary GC is high, it is limited to the analysis of 
volatile analytes or their derivatives. HPLC has lower separation efficiency than 
capillary GC. The utility of TLC is limited by its low separation efficiency and narrow 
linear range in detection.  
CE has proven to be a powerful tool for the separation of enantiomers. In 
addition to its high resolving power and low consumption of sample and solvent, it 
demonstrates flexibility with regards to using and changing chiral resolving agents.16 
The main advantages of this technique include: (i) the broad variety of chiral resolving 
agents and (ii) the high efficiency attainable by CE.17  
 
1.2   Fundamentals of Capillary Electrophoresis (CE) 
In CE, molecules that are charged migrate under the influence of an electric field, 
with a certain electrophoretic velocity, ν
.
  This velocity is proportional to the electric 
field strength, E: 
                                             ν = µE                                                 (1) 
 
where the constant of proportionality, µ, called electrophoretic mobility, is a function of 
the ratio of the ionic charge (q) to the hydrodynamic radius (r) of the analyte ion, and 
viscosity (η) of the solution, expressed as: 
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     µ ηpi=
q
r6        (2) 
 
Zone electrophoretic separation is based upon the electrophoretic mobility differences 
among the analytes.  
 
1.2.1 Significance of Electroosmotic Flow (EOF) 
In CE, fused silica capillaries are most commonly used for separation. When the 
capillary is filled with background electrolyte (BGE), the silanol groups on the surface 
of the fused silica capillary partially dissociate forming SiO- and hydronium ions. The 
extent of the dissociation of the silanol groups depends on the pH of the BGE.  Thus, 
immobilized negative charges can be created on the inner wall of the capillary.  In order 
to maintain electric neutrality, some of the positive ions in the BGE are strongly 
attracted to the wall forming a “fixed” or Stern layer.  The remaining cations which are 
less-tightly held are in the diffused (Gouy-Chapman) layer farther out into the solution. 
This leads to the formation of a double layer. The potential at the shear plane between 
the two layers is known as the zeta ( ζ ) potential.18 Upon application of a potential 
across the length of the capillary, the solvated cations in the diffuse layer migrate toward 
the cathode at a constant velocity, dragging along their hydrated layer (bulk solvent 
molecules).  Thus, a bulk flow of the BGE, electroosmotic flow, is obtained in the 
capillary.  
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The electroosmotic velocity (νeo), relates to the permittivity of the medium (ε), 
the dielectric constant (ε0), the zeta potential (ζ), the dynamic viscosity of the medium 
(η), and the applied electric field strength (E) as:19 
 
                  ν
ε εζ
η
µeo eo= − =0 Ε Ε                (3) 
 
The negative sign is an indication of the direction of the bulk flow toward the cathode.  
The most pronounced property of EOF is its  flat or plug-like flow profile, compared to 
the parabolic flow profile of pressure-driven flow observed in HPLC.20 This eliminates 
the most significant band broadening mechanism, related to the parabolic flow profile 
observed in HPLC, which leads to high separation efficiency in CE than in HPLC.  
With a sufficiently high EOF, it is possible to detect cations, anions and 
uncharged molecules in a single CE run.  
 
1.2.2 Significance of BGE 
 The BGE regulates the pH of the system in addition to conducting electric 
current for the separation of analytes. As such, BGEs must contain enough ions to 
transport the electric current. Furthermore, the BGE must have significant buffering 
capacity at the selected pH.21 When electric current is generated by the application of 
voltage across the capillary, the temperature of the solution inside the capillary increases 
due to Joule heating. As a result, the properties of the BGE including its viscosity and 
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the mobility of the EOF are affected. According to, e.g., Ryslavy et al.,22 Joule heat will 
also cause temperature differences (∆T) between the walls and the center of the 
capillary. They reported that ∆T depends on the electric field strength (E), the 
conductivity of the solution (k) and the radius of the capillary (r) as: 
 
                                                     ∆T ~ E 2k r2                                              (4) 
 
The radial temperature difference leads to a radial velocity distribution that causes extra 
peak broadening which, in turn, decreases separation efficiency and peak resolution. 
From equation 4, low conductance BGEs and small internal diameter capillaries are 
preferred. 
 The mobility of EOF depends on the pH and the ionic strength (I) of the BGEs. 
Likewise, the effective mobility of an analyte depends on the ionic strength of the BGE 
and the effective charge, z of the analyte as expressed by the equation:18,23 
 
                                            
µ
µ
eff
zI
0
1 20 77= −exp( . )( ) /                                      (5) 
 
where µ0 is the ionic mobility at infinite dilution. The ionic strength19 of the BGE, I, is 
defined as  
 
                                                   I c zi i= ∑
1
2
2
                                                (6) 
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where c is the concentration and z is the charge of the ionic species of the BGE.  
Charged analytes migrate with their observed mobility, µobs, which is a 
combination of their effective electrophoretic mobility, µeff, and the non-selective 
electroosmotic mobility, µeo, given by 
 
               µ µ µobs eff eo= +                                          (7) 
 
1.3 Chiral Resolving Agents Used in CE 
Several chiral resolving agents have been used in CE separations. Examples 
include macrocyclic antibiotics,24-29 proteins,30-32 chiral crown ethers,28, 30, 33 linear oligo- 
and polysaccharides,34, 35 and cyclodextrins (CDs). Although proteins and macrocyclic 
antibiotics are good chiral resolving agents, they adsorb on the capillary wall and also 
absorb UV light. Linear oligosaccharides complex with analytes weakly compared with 
cyclodextrins.30, 35 Chiral crown ethers bind only enantiomers that contain primary 
amino groups which limits their applicability. Moreover, BGEs used for separations 
involving chiral crown ethers are restricted to cations other than potassium and 
ammonium ions.33 Up to date36, CDs still remain the most dominant chiral resolving 
agents employed in CE enantioseparations.  
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1.4 Cyclodextrins and Principle of Chiral Recognition  
CDs are neutral, cyclic, non-reducing oligosaccharides that contain 6, 7 or 8 D 
(+) - glucopyranose units bonded through α-1,4-glycosidic linkages.37 CDs having 6, 7 
and 8 glucopyranose units are called α-, β- and γ-cyclodextrins, respectively. The native 
CD, shown in idealized form in Figure 1 is a hallow,  truncated cone having an axial 
cavity with primary hydroxyl groups around its narrower rim and, secondary hydroxyl 
groups on the opposite, wider rim.38 The outside of CD is hydrophilic due to the 
presence of primary and secondary hydroxyl groups, which allow dissolution in the 
aqueous BGE while the cavity of the CD is hydrophobic.16 The crystallographic 
diameter of the hydrophobic cavity is 0.57, 0.78 and 0.95 nm for α-, β-, and γ-CD, 
respectively.39 Chiral recognition in CDs comes from the five asymmetric chiral carbon 
atoms on each glucopyranose unit.40 Enantioselectivity, which is based on the formation 
of temporal diastereoisomer complexes can be rationalized with the help of a three-point 
interaction model.41 Depending on the inner diameter of the cavity of the CDs and the 
size of the enantiomer, the enantiomer can form host-guest complexes in dynamic 
equilibrium with CDs through full or partial inclusion into cavities of the CDs. 
Stabilization of these complexes is influenced by steric parameters of the enantiomer, 
and also by the possibility of creating intermolecular interactions, including van der 
Waals,  charge transfer type (pi-pi), dipole-type, hydrophobic, hydrogen bonding or 
electrostatic interactions between substituents of the CD and the enantiomers.42 The 
strength of interaction of the two enantiomers with the CD molecule can be different 
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from each other, which leads to different complexation constants. This, in turn, leads to 
different electrophoretic mobilities and possibly CE separation. 
 
 
 
 
 
 
 
   
 
                           Top view                                                           Side view                                                                                
Figure 1.  Idealized structure of β-cyclodextrin 
 
Accurate description of the chiral recognition mechanism is still lacking at the 
molecular level,43 though NMR spectroscopy and X-ray crystallography have been used 
to provide direct evidence for the binding of enantiomers to chiral selectors.44  
 
1.5 Cyclodextrins as Chiral Resolving Agents in CE 
The advantages of CDs compared to other resolving agents include their UV 
transparency and solubility in aqueous solutions.45 CDs used for enantioseparation in CE 
include the native species as well as those modified with charged and non-charged 
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functional groups. Neutral CDs include native α-, β-, and γ-CDs and those derivatized 
with methyl, acetyl or hydroxypropyl groups. Neutral CDs are, however, not applicable 
for analysis of neutral enantiomers. Also, native CDs exhibit lower aqueous solubilities 
compared to their functionalized derivatives: the solubility of β–cyclodextrin is 16mM38 
while 40mM46 has been reported for heptakis(2,6-di-O-methyl)-β-CD. Carboxylic acids, 
dialkyl- and trialkylamine derivatives are examples of weakly acidic and weakly basic 
charged CDs.  The major limitation of these derivatives is that their charge state is pH 
dependent.47 Sulfated and sulfoalkyl ether CDs and quaternary ammonium CDs are 
examples of strongly acidic and strongly basic charged CDs. The charge state of these 
permanently charged CDs is pH independent.  Quaternary ammonium CDs however do 
adsorb onto the walls of the fused silica capillary.  Therefore, sulfated CDs are preferred 
for CE separations.   
Sulfated CDs that are commercially available are random mixtures of isomers 
with different degrees of substitution. For a given enantiomer pair, each CD isomer 
exhibits a unique binding characteristics. As a result, it would be difficult to predict the 
outcome of interactions with a particular analyte. In addition, the possibility of 
conducting a systematic study of chiral CE enantioseparation at the molecular level as 
well as robust method development would be hindered.48  In order to eliminate problems 
associated with the randomly sulfated CDs, single-isomer, sulfated cyclodextrins 
(SISCDs) need to be synthesized.   
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1.5.1 Synthetic Strategies for Selective Modification of Cyclodextrins 
Generally, SISCDs are made by adopting protecting and deprotecting synthetic 
schemes. It is reported49 that the selective functionalization of the primary and secondary 
hydroxyl groups of CD is not trivial.  However, several synthetic strategies have been 
developed to selectively functionalize either all the primary hydroxyl groups50 or all the 
secondary hydroxyl groups.51  These include:  i) one step extensive per-functionalization 
of 6-hydroxyl groups; ii) two step bi-functionalization of hydroxyl groups at C-2 and C-
6 positions with identical groups; iii) two step modification of the hydroxyl groups at C-
2 and C-6 with different substituents. Complexity of the problem is increased if selective 
functionalization of all the hydroxyl groups at the 2-position and none at the 3-position, 
is desired. Methods available to achieve such control are often cumbersome or provide 
low yield of the desired product.52 The hydroxyl groups at the 6-position with pKa = 15-
16 are the most reactive due to low steric hinderance.  The hydroxyl groups at the 2-
position are the most acidic with a pKa of 12.1. The hydroxyl group at the 3-position are 
the least reactive and resist functionalization.  This has been attributed to hydrogen bond 
formation between the protons of the hydroxyl groups at the 3-position and the oxygen 
atoms of the hydroxyl groups at the 2-position.53   
The tert-butyldimethylsilyl (TBDMS) group has proved to be a valuable 
protecting group in CDs because it can be selectively attached to the primary 6-hydroxyl 
groups of CDs.54 Rong and D’Souza55 reported a new convenient strategy for 
functionalization of the 2-position of CDs by NaH to form an alkoxide that readily reacts 
with an electrophile.  This strategy offers regioselective persubstitution of the 2-
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hydroxyl groups. Subsequent protection and deprotection steps can be performed to 
allow the functionalization of hydroxyl groups in the 3-position and 6-position, 
independently of one another. 
These regioselective persubstitution modification techniques were exploited in 
the synthesis of the novel SISCD described in this dissertation. 
 
1.5.2 Use of SISCD for Enantioseparation by CE 
SISCDs are reliable and effective resolving agents for robust CE 
enantioseparations.56 Several SISCDs have been synthesized and employed for the 
electrophoretic separation of enantiomers including acids, bases, neutrals and 
ampholytics using different concentrations of CDs and pH in aqueous57 and methanolic58 
BGEs. Heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-CD,59 heptakis(6-O-sulfo)-β-CD ,60 and 
heptakis(2,3-di-O-methyl-6-O-sulfo)-β-CD 61 analogs were the first SISCDs used for CE 
enantioseparations. Further research led to the development of the corresponding α-57, 62, 
63
 and γ-CD64-67 derivatives. Recently, the first set of SISCDs carrying non-identical 
substituents at all the C2, C3, and C6 positions, namely heptakis(2-O-methyl-3-O-acetyl-
6-O-sulfo)-β-CD68 and heptakis(2-O-methyl-6-O-sulfo)-β-CD69 were reported. Another 
derivative carrying sulfate groups at both the C3 and C6 positions, heptakis(2-O-methyl-
3,6-di-O-sulfo)-β-CD has been synthesized and its enantiorecognition behavior has also 
been investigated.70 All these derivatives thus far carry the sulfate group at either the C3 
or C6 positions. In order to have a better understanding of the role of the sulfate moiety 
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in enantiorecognition, SISCDs that carry the sulfate group exclusively at C2 position of 
the glucopyranose units have to be synthesized. 
 
1.5.3 SISCDs and Separation Models  
To better understand the different factors (including type of CD, the 
concentration of CD and pH) involved in enantiorecognition and also aid method 
development for CE enantiomer separations, two major theoretical models were 
developed. The first model, reported by Wren and Rowe71-74 for neutral cyclodextrins 
and based on secondary equilibria, showed that the difference in the apparent 
electrophoretic mobility between enantiomers is related to the differences between the 
complexation contants of the enantiomers, the mobilities of the free and the complexed 
analytes, and the concentration of the chiral resolving agent expressed as: 
 
                      ∆µ µ µ= − −
+ + +
[ ]( )( )
[ ]( ) [ ]
C K K
C K K K K C
1 2 2 1
1 2 1 2
21
                      (8) 
 
where ∆µ is the apparent mobility difference between the enantiomers, C is the 
concentration of the chiral selector, µ1 is the mobility of the analyte in free solution, µ2 is 
the mobility of the analyte-chiral selector complex and K1 and K2 are binding constants 
of the enantiomers. From equation 8, they indicated that there exits an optimum CD 
concentration expressed as a function of the two enantiomer-CD binding constants as: 
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                                           [ ]C
K K
opt
=
1
1 2
                                 (9) 
 
where K1 and K2 are the binding constants for the enantiomer-CD complexes. This 
model was verified experimentally by native β-CD and randomly methylated β-CD. This 
approach considers mobility difference rather than peak resolution.  
Major limitation of the model include the exclusion of important operational 
parameters such as pH of the BGE, electric field strength and electroosmotic mobility. 
 The second model, called the Charged Resolving Agent Migration model 
(CHARM model) developed by Williams et al.47 for the rational, predictable design of 
the separation of chiral weak electrolyte (including weak acids and weak bases) and 
neutral analytes with charged chiral resolving agents takes into account the effect of pH 
on separation selectivity. This secondary equilibra-based model looks at resolution and 
separation selectivity as a function of the concentration of the charged single-isomer 
cyclcodextrin (CCD) and pH of the BGE. For a 1:1 complex between the CCD and the 
analyte, the resulting effective mobility of one of the enantiomers can be expressed as: 
 
           µ µ µ µ µReff R RCD RCD HR HRCD HRCD
RCD HRCD
K CD K H O K CD
K CD K H O K CD
=
+ + +
+ + +
0 0
3
0 0
31 1
[ ] [ ]( [ ])
[ ] [ ]( [ ])         (10) 
 
where µoR and µoRCD, µo HR and µoHRCD are the ionic mobilities of the uncomplexed and 
fully complexed species, KRCD and KHRCD are the complexation coefficients for the non-
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protonated and the protonated forms of the enantiomer, K is the acid dissociation 
constant for the enantiomer, and [H3O] and [CD] are the concentrations of the 
hydronium ion and the resolving agent. 
Separation selectivity, α, for a given enantiomer pair, offered by a particular CD 
concentration is described as: 
 
                                                      α
µ
µ=
1
2
eff
eff                                                       (11) 
 
where subscripts 1 and 2 refer to the more and less mobile enantiomer, respectively. In 
an ideal CE system, where peak dispersion is caused only by longitudinal diffusion, peak 
resolution47 is expressed as: 
 
                           R
ELe
kT
z z
z z
s
o
eff eff
eff eff
= ×
− + +
+ + +8
1 1
1
1 2
3
1
3
2
α α β β
α β α β
                  (12) 
 
Here, E is the electric field strength, k is the Boltzman contant, e0 is the electric charge, 
T is the absolute temperature, l is the capillary length from injector to the detector, zieff is 
the effective charge of the solutes, and β is the normalized electroosmotic mobility 
calculated as: 
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Thus, peak resolution depends on α, β and zeff as shown in Figure 2. In addition to 
selectivity optimization, the key to the development of enantiomer separations lies in 
optimizing the β term through the use of a coated capillary and/or appropriate 
background electrolyte constituents. By optimizing β  and knowing the dependence of α, 
and zieff on the composition of the BGE, resolution can be achieved.         
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Peak resolution surfaces for 7-charged and 14-charged cyclodextrins as a 
function of separation selectivity and normalized electroosmotic mobility 
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According to equation 12 when all other parameters are equal, resolution 
increases with the square root of zieff. The three-dimensional resolution surface in Figure 
2 indicates that resolution increases with the effective charge as long as the other 
parameters remain the same. Under identical α and zeff, peak resolution increases 
towards infinitely high values as β approaches -1. As long as the cyclodextrin shows 
some selectivity for the enantiomers, peak resolution can be improved by optimizing β at 
the expense of increasing analysis time. It also shows that initially, peak resolution 
increases linearly with α.   
According to the predictions of the CHARM model, three types of enantiomer 
separations are possible for weakly basic and acidic analytes: ionoselective, 
desionoselective and duoionoselective separations. Ionoselective separation occurs when 
only the dissociated forms of the enantiomers complex selectively with the charged CD. 
On the other hand, desionoselective separation is achieved when the nondissociated 
forms of the enantiomers complex selectively with the charged CD. When both the 
dissociated and nondissociated forms complex selectively with the charged CD, 
duoselective separation is achieved.47 Peak resolution, according to the CHARM model 
for weak electrolytes, depends on the pH of the BGE. For ionoselective separation of 
weak bases and desionoselective separation of weak acids, peak resolution is high at low 
pH. For desionoselective separation of weak bases and ionoselective separation of weak 
acids peak resolution is high at high pH. Peak resolution for duoselective separation of 
both weak acids and weak bases is high at both low and high pH. For neutrals and 
permanently charged analytes, peak resolution values are similar at all pH values. 
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Practically, the most efficient approach to chiral CE separation method development is 
the use of only two stock BGEs: one at low pH and the other at high pH.47 
This dissertation will discuss the synthesis and characterization of the first single-
isomer sulfated CD that carriers the sulfate group exclusively at C2 position, heptakis(6-
O-acetyl-3-O-methyl-2-O-sulfo)-β-CD. The possibility for unique separation selectivity 
offered by charged sulfate groups on the chiral face of the cyclodextrin is of particular 
interest. A single-isomer, 2-sulfated CD would add to the arsenal of chiral resolving 
agents available for separations and permit the study of selectivity and resolution for 
various enantiomers, and aid in the rational design of chiral separations according to the 
CHARM model. 
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CHAPTER II 
SYNTHESIS AND CHARACTERIZATION OF HEPTAKIS(2-O-SULFO-3-O-
METHYL-6-O-ACETYL)CYCLOMALTOHEPTAOSE (HAMS) 
 
Single-isomer CD derivatives used as chiral resolving agents in capillary 
electrophoresis can carry the sulfo groups either at the C2, C3 or C6 positions. There are 
no reports on the synthesis or use of a single-isomer cyclodextrin that carries the sulfo 
moiety at the C2 position. This chapter describes the synthesis of the first single-isomer 
β-CD derivative that is sulfated at the C2 position, the sodium salt of heptakis(2-O-sulfo-
3-O-methyl-6-O-acetyl)cyclomaltoheptaose (HAMS). 
 
2.1 Materials and General Methods 
β-cyclodextrin was purchased from Cerestar, (Cedar Rapids, IA). tert-
Butyldimethylsilyl chloride (TBDMS) was obtained from FMC Lithium Div. (Bessemer 
City, NC). Imidazole (Im) was obtained from ChemImpex (Wood Dale, IL). 
Tetrabutylammonium iodide (TBAI), sodium hydride (60% dispersion in oil), 
iodomethane and sulfur trioxide pyridine complex were purchased from Aldrich 
Chemical Co. (Milwaukee, WI). Hydrofluoric acid, acetic anhydride and all reaction 
solvents were obtained from Mallinckrodt Chemical Co. (St. Louis, MO). Activated, 4Å- 
molecular sieves from Fischer Scientific, Inc. (Fairlawn, NJ) were used to dry the 
solvents. For some of the β-CD intermediates, progress of the reaction was monitored by 
aluminium backed Silica-60 TLC plates, obtained from E.M. Science (Gibbstown,NJ). A 
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staining solution, composed of 35g α-napthol, 140 ml conc. sulfuric acid, 420ml ethanol 
and 88ml deionized water was used to visualize spots of the cyclodextrin derivatives. 
Visualization was accomplished by dipping the developed TLC plates into the staining 
solution, then heating them in an oven at 110ºC for 10 minutes. An HPLC system 
containing a programmable solvent delivery module 126 ( Beckman-Coulter, Fullerton, 
CA), a Sedex Model 55 evaporative light scattering detector (S.E.D.E.R.E., Alfortville, 
France), and an AD 406 data acquisition system operated under Gold 8.1 software 
control (Beckman-Coulter) running on a 486DX4 personal computer (Computer 
Associates, College Station, TX) was used to establish the purity of all intermediates. 
Separations were obtained on a 4.6 mm I. D. × 250 mm analytical column packed with a 
5µm Luna C18 stationary phase (Phenomenex, Torrance, CA). The purity values 
reported in this dissertation were calculated with the assumption that the response factors 
of the evaporative light scattering detector were the same for all CD isomers. The 
progress of the sulfation reaction and the purity of the sulfated β-CD product were 
monitored by hydrophilic interaction chromatography (HILIC) using a 4.6 mm I. D. × 
150 mm analytical column packed with a 3µm Luna HILIC stationary phase 
(Phenomenex, Torrance, CA). 
1H, 13C and DEPT NMR spectra were obtained on Varian 300 and 500 MHz 
UnityPlus Spectrometers equipped with a 1H/19F/31P/13C quad probe, using VnmrJ 2.2 
C/D and Red Hat Linux softwares. 2-D NMR experiments including 1H-1H correlation 
spectroscopy (1H-1H COSY) and 1H-13C heteronuclear correlation spectroscopy were 
used for assignment of the proton and carbon signals. 
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The molecular mass of the intermediates was obtained by high resolution 
MALDI-TOF-MS. A Voyager Elite XL TOF mass spectrometer equipped with delayed 
extraction capability (PerSeptive Biosystems, Framingham, MA) and operated in 
reflectron mode with an acceleration voltage of 25 kV, 70% grid voltage, 0.035% guide 
wire voltage, and a delay time of 180 µs, was used to collect the high-resolution mass 
spectra. The analytes were spotted onto a Teflon target plate using the dried droplet 
method.75 The matrix was prepared by dissolving 10 mg 2,4,6-trihydroxyacetophenone 
(THAP) in 1 mL acetonitrile.76  
The molecular mass of the final product was obtained by ESI-TOF-MS with a 
Vestec Model 201-A single quadrupole mass spectrometer equipped with a Vestec 
electrospray ion source (PerSeptive Biosystems). The sample was prepared at a 
concentration of 2 mg/mL in an acetonitrile : water 1:1 (v/v) solvent mixture. 
All electrophoretic measurements were made using a P/ACE 5010 system 
(Beckman-Coulter) equipped with a variable wavelength UV detector operated at 214 
nm and a 26.4 / 19.6 cm long, 25 µm I. D. bare fused silica capillary column (Polymicro 
Technologies, Phoenix, AZ). The applied potential was varied between 5 and 25 kV. The 
cartridge coolant of the P/ACE 5010 was thermostated at 20oC. The P/ACE 5010 system 
was interfaced with a 486DX-66 IBM personal computer. 
 
2.2 Synthesis and Characterization of HAMS 
Regioselective protection and deprotection methods were employed for 
functionalization of the hydroxyl groups at the 2, 3 and 6-C positions of β-CD. HAMS 
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was synthesized according to the scheme shown in Figure 3. The details of the synthetic 
procedure are outlined in the Appendix. 
 
 
 
 
 
Figure 3. Synthesis scheme for HAMS  
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2.2.1 Heptakis(6-O-t-butyldimethylsilyl)cyclomaltoheptaose, Intermediate (1) 
According to a modified procedure of Takeo,54 the primary hydroxyl groups at 
the C-6 positions of β-CD were reacted in DMF with t-butyldimethylchlorosilane 
dissolved in ethyl acetate. The progress of the reaction was monitored by isocratic non-
aqueous RP-HPLC using a 5µm Luna, C18 column and a 70 : 30 MeOH : EtOAc mobile 
phase at a flow rate of 2 ml/min, at ambient temperature.  ImHCl generated in the 
reaction was filtered out at the end and the solvent was removed under vacuum. The 
crude product was recrystallized from a DMF/acetone/water solvent mixture and dried in 
vacuo. The isomeric purity of intermediate (1) was > 99%. Figure 4 shows a 
chromatogram of the recrystallized product overlaid with a chromatogram of the mother 
liquor. 
1H and 13C NMR spectra are shown in Figures 5 and 6, respectively. Peak 
assignments were determined from the DEPT and 2-dimensional 1H-1H COSY and 1H-
13C HMQC NMR spectra shown in Figures 6, 7 and 8, respectively. 1H NMR data in 
CDCl3:  δ 6.73, 5.27 (singlet, exchangeable, OH-3 and OH-2); δ 4.89 (doublet, 7 H, J1-2 
= 3.5 Hz, H-1); δ 4.03 (triplet, 7 H, J3-4 = 9.0 Hz, H-3); δ 3.90 (doublet, 7 H, J6-6′  = 10.8 
Hz, H-6); δ 3.71 (doublet, 7 H, J6′-6  = 10.8 Hz, H-6′6); δ 3.63 (multiplet, 14 H, H-2,5); δ 
3.55 (triplet, 7 H, J4-3 = 9.0 Hz, H-4); δ 0.86 (singlet, 63 H, Si(CH3)2(C(CH3)3)); δ 0.04 
and δ 0.03 (two sets of singlets, 42 H, Si(CH3)2(C(CH3)3). 
 
 23
  
13C NMR data in CDCl3: δ 102.13 (C-1); δ 81.89 (C-4); δ 73.73 (C-2); δ 73.53 
(C-3); δ 72.67 (C-5); δ 61.75 (C-6); δ 26.04 (Si(CH3)2(C(CH3)3)); δ 18.41 
(Si(CH3)2(C(CH3)3)); δ -4.93, -5.05  (Si(CH3)2(C(CH3)3)).   
The 1H-1H COSY and 1H-13C HMQC NMR spectra show the proton and carbon 
contour signals that correspond to the glucopyranose subunits. The portion belonging to 
the t-butyldimethylsilyl group was omitted, because it is far away from those 
corresponding to the glucopyranose units, and can be assigned unambiguously. 
High resolution MALDI-TOF mass spectrometry was used to determine the 
molecular mass of intermediate (1). The Na+ and K+ ion-adduct portion of the mass 
spectrum of intermediate (1) is shown in Figure 9.  The calculated monoisotopic m/z 
values for the Na+ and K+ ion-adducts are 1955.96 and 1971.94 and agree well with the 
values obtained using MALDI-TOF-MS, 1955.61 and 1971.55,  indicating the presence 
of  seven t-butyldimethylsilyl groups on intermediate (1). 
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Figure 4. HPLC-ELSD chromatogram of A) recrystallized intermediate (1) and B) 
mother liquor 
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Figure 5. 1H NMR spectrum of intermediate (1) in CDCl3 
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Figure 6. A) DEPT and B) 13C NMR spectra of intermediate (1) in CDCl3 
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Figure 7. 2D COSY NMR spectrum of intermediate (1) in CDCl3  
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Figure 8. 1H-13C HMQC NMR spectrum of intermediate (1) in CDCl3  
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Figure 9. The Na+ and K+ ion-adduct portion of the MALDI-TOF mass spectrum of 
intermediate (1) 
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2.2.2 Heptakis(2-O-benzyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose, 
Intermediate (2) 
Attempts to use a benzyl moiety as a protecting group for the hydroxyl group at 
C2 with BaO and Ba(OH)2 as bases in DMF lead to: i) long reaction time (18h), ii) 
incomplete substitution at the C2 positions and iii) poor regioselectivity over the 
hydroxyl groups at the C3 positions54 which, in turn, require extensive purification of the 
product. Instead, the procedure reported by Rong and D’Souza55 that relies on NaH as 
the base was adopted. Thus, the secondary hydroxyl groups at the C2 position were 
reacted in THF, at room temperature, with benzyl bromide using NaH as the base and 
TBAI as the catalyst. A conversion rate over 80% was achieved under 3 hours. Progress 
of the reaction was monitored by isocratic non-aqueous RP-HPLC using a 5µm Luna, 
C18 column and a 55 : 45 MeOH : EtOAc mobile phase, at a flow rate of 2 ml/min, at 
ambient temperature. The reaction was quenched by adding methanol to the reaction 
mixture. The NaI precipitate was filtered and the reaction solvent was removed under 
reduced pressure. The crude product was dissolved in dichloromethane and the target 
material precipitated out of solution with methanol. The isomeric purity of the product 
was determined to be greater than 99 %. Selective benzylation of the hydroxyl group at 
the C-2 position over the C-3 position was greatly influenced by the amount of excess 
NaH used in the reaction.  
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           Figure 10 shows a chromatogram of the recrystallized product overlaid with a 
chromatogram of the mother liquor.  
           The structure of intermediate (2) was verified by high-resolution 1H and 13C NMR 
spectroscopy. Peak assignments for the 1H and 13C NMR spectra shown in Figures 11 
and 12 were determined by DEPT and 2-dimensional 1H-1H COSY and 1H-13C HMQC 
NMR spectroscopy (spectra shown in Figures 12, 13 and 14, respectively). 1H NMR data 
in CDCl3: δ 7.40-7.30 (multiplet, 35 H, Ph); δ 4.97 (doublet, 7H, J = 11.5 Hz, CH2Ph); δ 
4.93 (singlet, exchangeable, OH-3); δ 4.77 (doublet, 7 H, J1-2 = 3.5 Hz, H-1); δ 4.72 
(doublet, 7H, J = 11.5 Hz, CH2Ph); δ 4.01 (triplet, 7 H, J3-4 = 9.0 Hz, J3-2 = 9.5 Hz, H-3); 
δ 3.86 (doublet, 7 H, J6-6′  = 10.5 Hz, H-6); δ 3.61 (doublet, 7 H, J6′-5  = 9.5 Hz, J6′-6  = 
10.5 Hz, H-6′6); δ 3.55 (doublet, 7 H, J5-4  = 9.5 Hz, J5-6′ = 9.5 Hz, H-5); δ 3.55 (triplet, 7 
H, J4-3 = 9.0 Hz, J4-5 = 9.5 Hz, H-4); δ 3.33 (doublet of doublets, 7 H, J2-1 = 3.5 Hz, J2-3 = 
9.5 Hz, H-2); δ 0.84 (singlet, 63 H, Si(CH3)2(C(CH3)3)); δ -0.02 and δ -0.03 (two sets of 
singlets, 42 H, Si(CH3)2(C(CH3)3).  13C NMR data in CDCl3: δ 137.88 (CPh); δ 128.85 
(CPh); δ 128.49 (CPh); δ 128.02 (CPh); δ 101.36 (C-1); δ 82.21 (C-4); δ 79.15 (C-2); δ 
74.09 (CH2Ph); δ 73.72 (C-3); δ 71.78 (C-5); δ 61.85 (C-6); δ 26.04 
(Si(CH3)2(C(CH3)3)); δ 18.40 (Si(CH3)2(C(CH3)3)); δ -4.98, -5.09  (Si(CH3)2(C(CH3)3)).  
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The 1H-1H COSY and 1H-13C HMQC NMR spectra show only the signals that 
correspond to the glucopyranose subunits. The portion belonging to the aromatic ring 
was omitted because it is far away from the portion corresponding to the glucose 
subunits, and can be unambiguously assigned. The resonance position of C-2 in 
intermediate (1) shifted from 73.73 ppm to 79.12 ppm in intermediate (2), which is 
significant compared to the shift observed for the other carbon atoms. This indicates that 
the benzyl group was attached at the C-2 position. 
High resolution MALDI-TOF mass spectrometry was used to determine the 
molecular mass of intermediate (2). The Na+ and K+ion-adduct portion of the mass 
spectrum of intermediate (2) is shown in Figure 15.  The calculated monoisotopic m/z 
values for the Na+ and K+ ion-adducts,  2586.29 and 2602.27, agree well with the values 
obtained by MALDI-TOF-MS, 2586.58 and 2602.55,  indicating the presence of  seven 
benzyl groups on intermediate (2). 
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Figure 10. HPLC-ELSD chromatogram of A) recrystallized intermediate (2) and B) 
mother liquor 
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Figure 11. 1H NMR spectrum of intermediate (2) in CDCl3 
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Figure 12. A) DEPT and B) 13C NMR spectra of intermediate (2) in CDCl3 
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Figure 13. 2D COSY NMR spectrum of intermediate (2) in CDCl3  
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Figure 14. 1H-13C HMQC NMR spectrum of intermediate (2) in CDCl3  
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Figure 15. The Na+ and K+ ion-adduct portion of the MALDI-TOF mass spectrum of 
intermediate (2) 
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2.2.3 Heptakis(2-O-benzyl-3-O-methyl-6-O-t-
butyldimethylsilyl)cyclomaltoheptaose, Intermediate (3) 
Methylation of intermediate (2) was accomplished in THF using methyl iodide 
and sodium hydride, at room temperature, following a modified procedure reported by 
Cai and coworkers.77 The reaction was monitored by TLC using a developing solvent 
mixture of hexane : EtOAc 8 : 1. The reaction was quenched by methanol and the 
solvent was removed under reduced pressure. The crude product was digested in 
dichloromethane and NaI was filtered.  The crude product was recrystallized from a 
mixture of ethanol and H2O. The purity of the final product was determined by isocratic 
non-aqueous RP-HPLC using a 5µm Luna, C18 column and a 55 : 45 MeOH : EtOAc 
mobile phase, at a flow rate of 2 ml/min, at ambient temperature. The isomeric purity of 
the product was determined to be greater than 99 %. Figure 16 shows a chromatogram of 
the recrystallized product. 
Structural identity of intermediate (3) was established by high-resolution 1H and 
13C NMR spectroscopy. Peak assignments for the 1H and 13C NMR spectra shown in 
Figures 17 and 18 were determined by DEPT and 2-dimensional 1H-1H COSY and 1H-
13C HMQC NMR spectroscopy (spectra shown in Figures 18, 19 and 20, respectively). 
1H NMR data in CDCl3: δ 7.42-7.25 (multiplet, 35 H, Ph); δ  5.22 (doublet, 7 H, J1-2 = 
3.5 Hz, H-1); δ 4.79 (doublet, 7H, J = 12.0 Hz, CH2Ph);  δ 4.72 (doublet, 7H, J = 12.0 
Hz, CH2Ph); δ 4.13 (doublet, 7 H, J6-6′  = 9.5 Hz, H-6); δ 3.79 (triplet, 7 H, J4-3 = 9.0 Hz, 
H-4); δ 3.68-3.63 (multiplet, 21 H,  H-3, H-5, H-6′); δ 3.54 (singlet, 21 H, CH3); δ 3.32 
(doublet of doublets, 7 H, J2-1 = 3.5 Hz, H-2); δ 0.86 (singlet, 63 H, Si(CH3)2(C(CH3)3)); 
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δ 0.12 and δ 0.00 (two sets of singlets, 42 H, Si(CH3)2(C(CH3)3).  13C NMR data in 
CDCl3: δ 139.06 (CPh); δ 128.22 (CPh); δ 127.65 (CPh); δ 127.33 (CPh); δ 98.44 (C-1); δ 
82.24 (C-3); δ 79.97 (C-2); δ 78.47 (C-4); δ 72.53 (CH2Ph) δ 72.36 (C-5); δ 62.45 (C-6); 
δ 61.59 (CH3); δ 26.06 (Si(CH3)2(C(CH3)3)); δ 18.44 (Si(CH3)2(C(CH3)3)); δ -4.71, -
5.05  (Si(CH3)2(C(CH3)3)).  
The 1H-1H COSY and 1H-13C HMQC NMR spectra show only the signals 
corresponding to the glucopyranose subunits. shift in the resonance position observed for 
C-3 (to 82.24 ppm in intermediate (3) from 73.72 ppm in intermediate (2)) indicated the 
attachment of the methyl group at the C-3 position.  
High resolution MALDI-TOF mass spectrometry was used to determine the 
molecular mass of intermediate (3). The Na+ and K+ion-adduct portion of the mass 
spectrum of intermediate (3) is shown in Figure 21.  The calculated monoisotopic m/z 
values of the Na+ and K+ ion-adducts of 2684.40 and 2700.38 agree well with the values 
obtained using MALDI-TOF-MS, 2684.46 and 2700.30, respectively,  indicating the 
presence of  seven methyl groups on intermediate (3). 
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Figure 16. HPLC-ELSD chromatogram of recrystallized intermediate (3) 
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Figure 17. 1H NMR spectrum of intermediate (3) in CDCl3 
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Figure 18. A) DEPT and B) 13C NMR spectra of intermediate (3) in CDCl3 
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Figure 19. 2D COSY NMR spectrum of intermediate (3) in CDCl3  
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Figure 20. 1H-13C HMQC NMR spectrum of intermediate (3) in CDCl3 
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Figure 21.  The Na+ and K+ion-adduct portion of the MALDI-TOF mass spectrum of 
intermediate (3) 
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2.2.4 Heptakis(2-O-benzyl-3-O-methyl)cyclomaltoheptaose, Intermediate (4) 
 Intermediate (3) was desilylated using 48% aqueous HF added to a mixture of 
THF and ethanol, in 24 hrs at room temperature. The reaction was monitored by TLC 
using a mobile phase of 50 : 10 : 1 CHCl3 : MeOH : H2O. Once desilylation was 
complete, NaOH dissolved in aqueous ethanol was added to neutralize the excess HF. 
The NaF precipitate was filtered and the solvent was removed under reduced pressure.  
The crude product was recrystallized from acetone. The isomeric purity of the final 
product, which is greater than 98 %, was determined by isocratic aqueous RP-HPLC 
using a 5µm Luna, C18 column and a 95 : 5 MeOH : H2O mobile phase, at a flow rate of 
2 ml/min, at ambient temperature. Figure 22 shows a chromatogram of the recrystallized 
product. The structure of intermediate (4) was confirmed by high-resolution 1H and 13C 
NMR spectroscopy. Peak assignments for the 1H and 13C NMR spectra shown in Figures 
23 and 24 were determined by DEPT and 2-dimensional 1H-1H COSY and 1H-13C 
HMQC NMR spectroscopy (spectra shown in Figures 24, 25 and 26). 1H NMR data in 
CDCl3: δ 7.43-7.27 (multiplet, 35 H, Ph); δ 5.03 (doublet, 7 H, J1-2 = 3.5 Hz, H-1); δ 
4.87 (broad, exchangeable, OH-6 ); δ 4.78 (doublet, 7H, J = 12.0 Hz, CH2Ph);  δ 4.71 
(doublet, 7H, J = 12.0 Hz, CH2Ph); δ 3.94 (doublet, 7 H, J6-6′  = 10.0 Hz, H-6); δ 3.85-
3.82 (multiplet, 14 H,  H-5, H-6′); δ 3.61 (triplet, 7 H, J3-4 = 9.0 Hz, H-3); δ 3.56-3.52 
(multiplet, 28 H,  H-4, CH3, ); δ 3.46 (doublet of doublets, 7 H, J2-1 = 3.5 Hz, H-2).  
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13C NMR data in CDCl3: δ 138.83 (CPh); δ 128.34 (CPh); δ 127.76 (CPh); δ 127.56 (CPh); 
δ 99.32 (C-1); δ 82.10 (C-3); δ 80.01 (C-4); δ 79.30 (C-2); δ 72.82 (CH2Ph); δ 72.66 (C-
5); δ 61.52 (C-6); δ 61.40(CH3). 
The 1H-1H COSY and 1H-13C HMQC NMR spectra (Figures 25 and 26) show 
only the signals that correspond to the CD backbone. Figure 23 clearly shows the 
complete removal of the t-butyldimethylsilyl group at the C-6 position from intermediate 
(3) while the benzyl and methyl groups at the C-2 and C-3 positions remain intact. 
High resolution MALDI-TOF mass spectrometry was used to determine the 
molecular mass of intermediate (4). The Na+ and K+ion-adduct portion of the mass 
spectrum of intermediate (4) is shown in Figure 27.  The calculated monoisotopic m/z 
values for the Na+ and K+ ion-adducts are 1885.80 and 1909.77, and agree well with the 
values obtained using MALDI-TOF-MS, 1885.78 and 1909.75, respectively,  indicating 
the complete removal of the t-butyldimethylsilyl groups from intermediate (3). 
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Figure 22. HPLC-ELSD chromatogram of recrystallized intermediate (4) 
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Figure 23. 1H NMR spectrum of intermediate (4) in CDCl3 
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Figure 24. A) DEPT and B) 13C NMR spectra of intermediate (4) in CDCl3 
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Figure 25. 2D COSY NMR spectrum of intermediate (4) in CDCl3  
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Figure 26. 1H-13C HMQC NMR spectrum of intermediate (4) in CDCl3 
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Figure 27. The Na+ and K+ion-adduct portion of the MALDI-TOF mass spectrum of 
intermediate (4)  
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2.2.5 Heptakis(2-O-benzyl-3-O-methyl-6-O-acetyl)cyclomaltoheptaose, Intermediate 
(5) 
 Acetylation of intermediate (4) was carried out in pyridine at 50ºC for 2.5 h, in 
the presence of excess acetic anhydride following a modified procedure reported by 
Vincent et al.59 Reaction progress was monitored by isocratic RP-HPLC using a 5µm 
Luna, C18 column and a 95 : 5 MeOH : H2O mobile phase at a flow rate of 2 ml/min, at 
ambient temperature. Upon completion, the reaction solvent and acetic acid were 
removed under vacuum. The crude product was dissolved in CH2Cl2 and the target was 
precipitated with hexanes. The product was dried in vacuo to yield intermediate (5) as a 
white powder at 99 % isomeric purity. Figure 28 shows a chromatogram of the 
recrystallized product.  
The structure of intermediate (5) was confirmed by high-resolution 1H and 13C 
NMR spectroscopy. Peak assignments for the 1H and 13C NMR spectra shown in Figures 
29 and 30 respectively were determined by DEPT and 2-dimensional 1H-1H COSY and 
1H-13C HMQC NMR spectroscopy (spectra shown in Figures 30, 31 and 32, 
respectively). 1H NMR data in CDCl3: δ 7.46-7.29 (multiplet, 35 H, Ph); δ 4.93 (doublet, 
7 H, J1-2 = 3.5 Hz, H-1); δ 4.77 (singlet, 14 H, CH2Ph); δ 4.45 (doublet, 7 H, J6-6′  = 8.5 
Hz, H-6);  
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δ 3.61 (doublet of doublets, 7 H, J6′-5  = 4.5 Hz, J6′-6  = 8.5 Hz, H-6′6); δ 3.55 (doublet of 
doublets, 7 H, J5-6′ = 4.5 Hz, J5-4  = 9.5 Hz, H-5); δ 4.01 (triplet, 7 H, J3-4 = 9.0 Hz, J3-2 = 
9.5 Hz, H-3); δ 3.57 (singlet, 21 H, CH3, ); δ 3.51 (triplet, 7 H, J4-3 = 9.0 Hz, J4-5 = 9.5 
Hz, H-4); δ 3.33 (doublet of doublets, 7 H, J2-1 = 3.5 Hz, J2-3 = 9.5 Hz, H-2); δ 2.06 
(singlet, 21 H, CH3CO). 13C NMR data in CDCl3: δ 170.63 (CH3CO); δ 138.76 (CPh); δ 
128.39 (CPh); δ 127.93 (CPh); δ 127.71 (CPh); δ 99.75 (C-1); δ 81.88 (C-3); δ 80.89 (C-
4); δ 79.40 (C-2); δ 73.05 (CH2Ph); δ 69.87 (C-5); δ 63.49 (C-6); δ 61.64 (CH3); δ 20.92 
(CH3CO).  
The 1H-1H COSY and 1H-13C HMQC NMR spectra (Figures 29 and 30), show 
only the signals corresponding to the glucopyranose subunits and indicate the presence 
of acetyl groups connected to the C-6 positions. 
High resolution MALDI-TOF mass spectrometry was used to determine the 
molecular mass of intermediate (5). The Na+ and K+ ion-adduct portion of the mass 
spectrum of intermediate (5) is shown in Figure 33.  The calculated monoisotopic m/z 
values of the Na+ and K+ ion-adducts are 2179.87 and 2195.84, which agree well with 
the values obtained using MALDI-TOF-MS, 2179.89 and 2195.90, respectively,  
indicating the presence of  seven acetyl groups on intermediate (5). 
 
 
 
 
 
 57
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. HPLC-ELSD chromatogram of recrystallized intermediate (5) 
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Figure 29. 1H NMR spectrum of intermediate (5) in CDCl3 
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Figure 30. A) DEPT and B) 13C NMR spectra of intermediate (5) in CDCl3 
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Figure 31. 2D COSY NMR spectrum of intermediate (5) in CDCl3  
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Figure 32. 1H-13C HMQC NMR spectrum of intermediate (5) in CDCl3 
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Figure 33. The Na+ and K+ ion-adduct portion of the MALDI-TOF mass spectrum of 
intermediate (5)  
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2.2.6 Heptakis(3-O-methyl-6-O-acetyl)cyclomaltoheptaose, Intermediate (6) 
Debenzylation of intermediate (5) was accomplished following a modified 
version of the procedure reported by Angibeaud et al.78  The reaction was carried out in a 
1:1 mixture of anhydrous MeOH and dioxane, using 10% Pd on activated charcoal as a 
catalyst, in an atmosphere of H2. Reaction progress was monitored by RP-HPLC using a 
5µm Luna, C18 column and gradient elution at a flow rate of 1 ml/min. The initial 
mobile phase composition was 80 : 20 H2O : ACN that was changed to 2 : 98 H2O : 
ACN in 15 min, at 40ºC. Upon completion of the reaction, the catalyst was filtered and 
the reaction solvent was removed under reduced pressure. The crude product was 
dissolved in CH2Cl2 and precipitated with hexanes to yield intermediate (6) as a white 
powder of 98% isomeric purity. Figure 34 shows a chromatogram of the recrystallized 
product. 
The structure of intermediate (6) was confirmed by high-resolution 1H and 13C 
NMR spectroscopy. Peak assignments for the 1H and 13C NMR spectra shown in Figures 
35 and 36, respectively, were determined by DEPT and 2-dimensional 1H-1H COSY and 
1H-13C HMQC NMR spectroscopy (spectra shown in Figures 36, 37 and 38, 
respectively). 1H NMR data in CDCl3: δ 4.93 (doublet, 7 H, J1-2 = 3.5 Hz, H-1); δ 4.63 
(doublet, 7 H, J6-6′  = 10.5 Hz, H-6); δ 4.50 (doublet, 7 H, J  = 9.5 Hz, OH-2); δ 4.06 
(doublet of doublets, 7 H, J6′-5  = 5.5 Hz, J6′-6  = 10.5 Hz, H-6′6); δ 4.01 (doublet of 
doublets, 7 H, J5-6′ = 5.5 Hz, J5-4  = 9.5 Hz, H-5); δ 3.73 (singlet, 21 H, CH3); δ 3.66 
(doublet of triplets, 7 H, J2-1 = 3.5 Hz, J2-3 = 9.5 Hz, H-2); δ 3.52 (triplet, 7 H, J3-4 = 9.5 
Hz, J3-2 = 9.5 Hz, H-3); δ 3.45 (triplet, 7 H, J4-3 = 9.5 Hz, J4-5 = 9.5 Hz, H-4); δ 2.06 
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(singlet, 21 H, CH3CO).  13C NMR data in CDCl3: δ 170.69 (CH3CO); δ 103.37 (C-1); δ 
83.09 (C-3); δ 80.21 (C-4); δ 73.76 (C-2); δ 70.41 (C-5); δ 62.89 (C-6); δ 59.69 (CH3); δ 
20.84 (CH3CO).  
The 1H-1H COSY and 1H-13C HMQC NMR spectra (Figures 37 and 38) show 
only the signals that correspond to the glucopyranose subunits. The 1H and 13C NMR 
spectra, Figures 35 and 36, respectively, show that all the benzyl groups at the C-2 
positions were removed from intermediate (5) while the acetyl and methyl groups 
remained intact. A significant upfield shift was seen for the C-2 carbon atoms, from 
79.40 ppm in intermediate (5) to 73.76 ppm in intermediate (6), confirming that the 
change occurred at the C-2 carbon atoms. 
High resolution MALDI-TOF mass spectrometry was used to determine the 
molecular mass of intermediate (6). The Na+ and K+ion-adduct portion of the mass 
spectrum of intermediate (6) is shown in Figure 39.  The calculated monoisotopic m/z 
values of the Na+ and K+ ion-adducts, 1549.54 and 1565.52, agree well with the values 
obtained using MALDI-TOF-MS, 1549.53 and 1565.50, respectively,  confirming the 
complete removal of the benzyl groups from intermediate (5). 
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Figure 34. HPLC-ELSD chromatogram of recrystallized intermediate (6) 
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Figure 35. 1H NMR spectrum of intermediate (6) in CDCl3 
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Figure 36. A) DEPT and B) 13C NMR spectra of intermediate (6) in CDCl3 
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Figure 37. 2D COSY NMR spectrum of intermediate (6) in CDCl3  
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Figure 38. 1H-13C HMQC NMR spectrum of intermediate (6) in CDCl3 
 
 
C4 C5C3C1 C2
CH3
C6
CDCl3
 70
 
 
1520 1540 1560 1580
0
10
20
30
40
50
60
70
80
90
100
In
te
n
si
ty
m/z
[M+Na]Calc  = 1549.54
[M+Na]Meas= 1549.53
[M+K]Calc  = 1565.52
[M+K]Meas= 1565.50
 
 
 
 
Figure 39. The Na+ and K+ion-adduct portion of the MALDI-TOF mass spectrum of 
intermediate (6)  
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2.2.7 Heptakis(2-O-sulfo-3-O-methyl-6-O-acetyl)cyclomaltoheptaose (HAMS) 
Following a modified procedure of Vincent et al.59, sulfation of intermediate (6) 
was conducted in DMF at 50ºC with an excess of sulfur trioxide pyridine complex using 
pyridine as the base. Reaction progress was monitored by HPLC using a 3µm Luna, 
HILIC column and gradient elution at a flow rate of 1 ml/min. The initial mobile phase 
composition was 100% A that was changed to 50% A : 50% B in 30 min (A: 5 mM 
HCOONH4 in 95% ACN,  B: 5mM HCOONH4 in H2O) at room temperature. Upon 
completion of the reaction, sodium bicarbonate was added to the reaction mixture and 
the sodium sulfate precipitate produced was filtered. The reaction solvents were 
removed under reduced pressure. The crude product was dissolved in a minimum 
amount of MeOH and the product was precipitated by pouring the solution into diethyl 
ether to yield the final product, HAMS, as a white powder of 97% isomeric purity. 
Figure 40 shows a chromatogram of the recrystallized product. 
The structure of HAMS was confirmed by high-resolution 1H and 13C NMR 
spectroscopy. Peak assignments for the 1H and 13C NMR spectra shown in Figures 41 
and 42, respectively, were determined by DEPT and 2-dimensional 1H-1H COSY and 
1H-13C HMQC NMR spectroscopy (spectra shown in Figures 42, 43 and 44, 
respectively).  
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1H NMR data in D2O: δ 5.33 (doublet, 7 H, J1-2 = 3.5 Hz, H-1); δ 4.38 (doublet, 7 
H, J6-6′  = 10.5 Hz, H-6);  δ 4.26 (doublet of doublets, 7 H, J6′-5  = 5.5 Hz, J6′-6  = 10.5 Hz, 
H-6′6); δ 3.66 (doublet of doublets, 7 H, J2-1 = 3.5 Hz, J2-3 = 9.5 Hz, H-2); δ 4.01 
(doublet of doublets, 7 H, J5-6′ = 5.5 Hz, J5-4  = 9.5 Hz, H-5); δ 3.79-3.72 (multiplet, 14 H,  
H-3, H-4 ); δ 3.58 (singlet, 21 H, CH3);  δ 2.07 (singlet, 21 H, CH3CO).  13C NMR data 
in D2O: δ 173.27 (CH3CO); δ 97.14 (C-1); δ 79.32 (C-3); δ 77.07 (C-2) δ 76.62 (C-4); δ 
69.08 (C-5); δ 63.51 (C-6); δ 60.67 (CH3); δ 20.22 (CH3CO).  
The 1H-1H COSY and 1H-13C HMQC NMR spectra (Figures 43 and 44) show 
only the signals that correspond to the glucopyranose subunits. The 1H and 13C NMR 
spectra, Figures 41 and 42, respectively, show that the acetyl groups at the C-6 position 
remained intact during sulfation of intermediate (6).  A significant downfield shift was 
seen for the C-2 carbon atoms; from 73.75 ppm in intermediate (6) to 77.07 ppm in the 
final product, HAMS, confirming that the change occurred at the C-2 carbon atoms. 
 High resolution MALDI-TOF mass spectrometry was used to confirm the 
molecular mass of HAMS. The Na+ ion-adduct portion of the mass spectrum of HAMS 
is shown in Figure 45.  The calculated monoisotopic m/z value of the Na+ ion-adduct, 
2263.11, agrees well with the value obtained using MALDI-TOF-MS, 2263.11.  
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Figure 40. HPLC-ELSD chromatogram of recrystallized final product (HAMS) 
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Figure 41. 1H NMR spectrum of final product (HAMS) in D2O 
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Figure 42. A) DEPT and B) 13C NMR spectra of final product (HAMS) in D2O 
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Figure 43. 2D COSY NMR spectrum of final product (HAMS) in D2O 
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Figure 44. 1H-13C HMQC NMR spectrum of final product ( HAMS) in D2O 
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Figure 45. The Na+ ion-adduct portion of the MALDI-TOF mass spectrum of final 
product (HAMS)  
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2.3 Summary 
 The synthesis of the sodium salt of HAMS for use as a chiral resolving agent in 
capillary electrophoretic separation of enantiomers has been accomplished via a seven-
step synthetic methodology. Key to the successful synthesis of this product lies in the 
regioselective protection and deprotection steps outlined in the synthetic scheme. 
Although the use of each of these procedures alone, along with extensive 
chromatographic purification steps,  has been reported in the literature, the modifications 
and their combination reported here permitted the making of large quantities of the 
intermediates at high purity, facilitating the synthesis of the final product. The structural 
identity of each intermediate and final product was ascertained by 1H NMR and 13C 
NMR, 2D NMR and MALDI- and ESI-TOF-MS analysis. Both gradient and isocratic 
HILIC and reversed-phased HPLC methods were developed for the determination of the 
respective isomeric purities, which were in excess of 97 % mol/mol. 
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CHAPTER III 
CE SEPARATION OF ENANTIOMERS  
 
Several single-isomer sulfated CD derivatives, carrying the sulfate groups on 
either the C3 or C6 positions of the glucopyranose units, have been used as chiral 
resolving agents in CE. Previous work has shown that the cavity size of the 
cyclodextrins, and the type of the substituents (hydroxyl, acetyl or methyl groups) play 
significant roles in the chiral recognition processes. However, the effect of the 
attachment position of the sulfate group on the enantiorecognition capabilities of CDs 
has not been fully investigated since a single-isomer sulfated CD carrying the sulfate 
groups on C2 positions had not been synthesized. This chapter describes the chiral 
recognition behavior of HAMS, a single-isomer CD carrying the sulfate moiety on the 
chiral face at the C2 position. Whenever possible, qualitative comparison was made 
between the separations achieved with HAMS and other β-functionalized SISCD.   
 
3.1 Materials 
All chiral analytes were obtained either from Aldrich Chemical Co. (Milwaukee, 
WI), Sigma (St. Louis, MO), Wiley Organics (Coshocton, OH) or Research Diagnostic 
(Rockdale, MD). Dimethylsulfoxide (DMSO) was purchased from EM Science 
(Gibbstown, NJ). All aqueous solutions used in these experiments were prepared from 
deionized water obtained from a Milli-Q unit (Millipore, Milford, MA). 0.45 µm 
Nalgene nylon membrane filters were purchased from VWR (South Plainfield, NJ). 
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Phosphoric acid and lithium hydroxide were purchased from Aldrich Chemical Co. 
HAMS was prepared as described in Chapter II. The stock buffer was prepared by 
titration of a 25 mM aqueous solution of H3PO4 (pKa1, 2.1) to pH 2.5 with LiOH. The 
chiral resolving agent-containing BGEs were prepared immediately prior to use by 
weighing out the required amount of the sodium salt of HAMS into 25 ml volumetric 
flasks and bringing the volume to mark with the stock buffer solution. 
 
3.2 CE Conditions and Methods 
All enantiomer separations were performed on either a P/ACE 5010 or a P/ACE 
2010 capillary electrophoresis instruments with their UV detectors set to 214 nm. A 26.4 
cm total length (19.6 cm to detector), 27 µm i.d., fused silica capillary (Polymicro 
Technologies, Phoenix, AZ, USA) was used for CE measurements. A UV detection 
window was prepared by removing a section of the polyimide coating by burning off 
with an electric coil heater.  The exposed capillary section was then wiped clean with 
methanol-soaked Kimwipe. All separations were obtained between 7 and 20 kV applied 
potential and 20 ºC cartridge coolant temperature. Between runs, the capillary was 
flushed with deionized water for 3 min, followed by the running buffer for 3 min. 
Dimethylsulfoxide (DMSO), which has been reported to have zero effective mobility 
with SISCDs,57 was selected as the electroosmotic flow (EOF) mobility marker for 
HAMS. Its suitability as a mobility maker has been experimentally verified.79 The 
enantiomers were dissolved in the cyclodextrin-containing BGE and either co-injected 
with the EOF marker by pressure for 1 s or the marker was injected separately followed 
 82
by electrokinetic injection of the enantiomers at 10 kV for 5s. The effective mobilities 
were measured against DMSO and these measurements were carried out within the 
linear region of Ohm’s law. All solutions were filtered prior to use with a 0.45 µm 
Nalgene nylon membrane filter. 
Separation selectivity (α) was determined as a function of the concentration of 
the chiral resolving agent in aqueous low pH BGEs. The effective mobilities (µeff) and 
the normalized electroosmotic mobilities (β) were calculated per equations 7 and 13 (see 
Chapter I), respectively. Peak resolution was calculated from peak half-height widths 
(wh) as: 
                                               Rs t t
w wh h
=
−
+
2
1699
2 1
2 1
( )
. ( )  
 
Migration time (t) values used were taken at the estimated point of infinite 
dilution for peaks suffering electromigration dispersion (EMD). Effective mobilities and 
separation selectivities were plotted as a function of the resolving agent concentration to 
evaluate the optimum chiral resolving agent concentration for the highest available 
separation selectivity. 
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3.3 Separations of Enantiomers of Weak Base Analytes Using HAMS in Low pH 
BGEs  
According to the CHARM model, when a strong electrolyte resolving agent, such 
as HAMS is used for enantioseparations, only two stock BGEs, one at low pH and 
another at high pH are required.47 Previous work has shown that a low pH BGE will 
provide good resolution values because more favorable β values can be obtained than in 
high pH BGEs. For ionoselective separation of weak base enantiomers, peak resolution 
is high at low pH.47 Thus, chiral recognition can be maximized by taking advantage of 
the electrostatic interaction between the SISCD and the protonated enantiomers, in 
addition to other intermolecular interactions that may also be present. Effective 
mobilities for singly-charged, weakly basic compounds usually lie between +10 and +35 
mobility units (10-5 cm2V-1s-1). Generally, at low pH, µeo values are between +10 to +25 
mobility units in fused silica capillaries. Previous work has shown that complexation of 
weak bases with SISCDs leads to anionic effective mobilities as high as -30 mobility 
units. This effect makes it possibility to adjust the SISCD concentration to bring about 
an effective mobility that is nearly equal in magnitude but opposite in direction to the 
EOF mobility in order to achieve resolution. It is therefore reasonable to evaluate the 
potential of a new SISCD for enantioseparation by beginning with weak base 
enantiomers in low pH BGEs.  
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3.3.1 Results and Discussion 
The structures of the thirty-three, structurally diverse, weakly basic enantiomers 
(mostly pharmaceuticals) selected to evaluate the utility of HAMS as a chiral resolving 
agent for use in CE enantiomer separations are shown in Figure 46. All thirty-three 
weakly basic compounds have been shown to have cationic effective mobilities under 
the selected conditions at 0 mM HAMS concentration. Shown in Table 1 are the 
effective mobilities of the less mobile enantiomer, µ, the separation selectivities, α, the 
calculated peak resolution, Rs, the corresponding dimensionless, normalized EOF 
mobility values, β, and the injector-to-detector potential drop values, U, obtained in the 
low pH aqueous BGEs for the weakly basic enantiomers. An entry of N/A indicates that 
a value could not be calculated due to overlap with either a non-comigrating system peak 
or overlap with the neutral marker peak. The applied potential was 20 kV in 0.5 mM 
HAMS-containing BGE and decreased with increasing HAMS concentration to 11 kV in 
the 20 mM HAMS-containing BGE. The mobility of the cathodic EOF (µEOF) was 
between 10 to 20 mobility units over the 0.5 to 20 mM HAMS concentration range, 
indicating that HAMS was adsorbed on the walls of the capillary. No studies were 
conducted to quantify the contribution of chromatographic retention of the effective 
migration of the analytes.  
There was at least some separation selectivity for the enantiomers of 27 of the 33 
weakly basic compounds tested within the HAMS concentration range studied. Of these, 
18 were baseline resolved (i.e., Rs > 1.5) under the conditions used. For six analytes, 
including atenolol, ketamine, mepenzolate bromide, metoprolol, tolperisone and 
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chlorpheniramine, there was no resolution. Atenolol and ketamine were weakly 
complexing at all HAMS concentrations. Mepenzolate bromide and chlorpheniramine 
have chiral centers sterically crowded by two aromatic rings. Even though metoprolol 
and tolperisone complex strongly with HAMS, lack of resolution may be due to 
unfavorable β-values provided by the separation conditions used. Although these 
explanations seem reasonable, NMR and X-ray crystallographic experiments are needed 
to aid our understanding of the enantiorecogntion process.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46. Names and structures of weakly basic analytes 
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Figure 46. Continued 
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Figure 46. Continued 
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Figure 46. Continued 
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Table 1. Separation data for the weak base analytes in pH 2.5 aqueous HAMS BGEs. (µ, 
in 10-5 cm2/Vs units) 
[CD] 0 mM 0.5mM 0.75mM
U (KV) 20 20 20
Analyte µ µ α β Rs µ α β Rs
B03 19.73 15.44 1.00 0.27 0.00 14.01 1.02 0.42 0.15
B04 23.65 20.32 1.00 0.27 0.00 19.30 1.00 0.33 0.00
B08 16.67 14.24 1.00 0.43 0.00 13.54 1.00 0.41 0.00
B09 25.57 10.75 1.17 0.54 1.27 8.88 1.24 0.73 1.73
B11 34.90 16.05 1.13 0.47 1.26 8.45 1.27 0.80 2.67
B13 23.28 2.61 <1.01 2.09 0.10 N/A
B14 17.62 4.91 1.82 1.11 3.80 1.58 3.64 4.88 4.35
B19 18.67 14.01 1.13 0.36 1.24 12.28 1.18 0.51 1.69
B20 30.80 22.81 1.00 0.24 0.00 18.05 1.00 0.46 0.00
B21 25.89 20.01 1.00 0.32 0.00 17.10 1.00 0.56 0.00
B22 28.90 21.50 1.00 0.26 0.00 18.02 1.00 0.39 0.00
B23 18.04 -3.96 -0.37 -2.02 3.64 -8.01 0.80 -1.31 4.67
B25 16.91 10.50 1.00 1.12 0.00 8.30 1.00 0.86 0.00
B26 20.36 17.67 1.00 0.33 0.00 16.75 1.00 0.48 0.00
B28 22.11 12.89 1.15 0.43 1.04 10.35 1.23 0.73 1.24
B30 17.92 14.90 1.03 0.39 0.43 13.45 1.06 0.52 0.60
B31 16.35 11.29 1.00 0.38 0.00 9.34 1.00 0.88 0.00
B33 19.70 9.95 1.03 1.07 0.18 6.10 1.07 2.45 0.41
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Table1.Continued
[CD] 1.0mM 2.0mM
U (KV) 20 19
Analyte µ α β Rs µ α β Rs
B03 12.66 1.04 0.62 0.78 8.45 1.10 1.70 0.95
B04 18.40 1.00 0.44 0.00 15.05 1.00 0.97 0.00
B08 12.80 1.00 0.61 0.00 10.39 1.00 0.70 0.00
B09 7.21 1.31 1.14 2.20 1.27 2.79 8.16 3.14
B11 5.51 1.41 1.48 2.81 -1.11 0.37 -6.22 3.31
B13 -5.03 0.88 -1.62 1.04 N/A
B14 N/A -7.01 0.45 -1.53 4.51
B19 10.63 1.22 0.83 2.19 5.67 1.56 1.37 2.77
B20 19.04 1.00 0.52 0.00 13.12 <1.01 0.49 <0.1
B21 14.98 1.00 0.69 0.00 11.55 1.00 0.59 0.00
B22 16.18 1.00 0.55 0.00 12.49 1.00 0.56 0.00
B23 -9.74 0.97 -1.35 0.37 N/A
B25 6.08 1.00 1.51 0.00 N/A
B26 15.90 1.00 0.66 0.00 12.89 1.00 0.65 <0.1
B28 7.96 1.33 1.21 1.75 1.54 2.10 9.17 1.89
B30 12.17 1.11 0.78 1.18 8.23 1.20 1.04 1.42
B31 7.75 1.00 1.23 0.00 2.48 1.00 4.55 0.00
B33 3.37 1.15 3.12 0.95 -3.30 0.79 -3.16 1.45
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Table1.Continued
[CD] 2.5mM 3.5mM
U (KV) 19 15
Analyte µ α β Rs µ α β Rs
B03 6.73 1.14 1.77 1.13 4.31 1.21 3.95 1.30
B04 13.47 1.00 1.05 0.00 N/A
B08 9.39 1.00 1.35 0.00 N/A
B09 -1.02 -2.15 -11.78 N/A -3.94 0.10 -4.31 3.81
B11 -3.49 N/A -4.04 N/A -6.57 0.59 -2.59 3.25
B13 -12.77 0.95 -1.06 1.21 N/A
B14 -9.78 0.55 -1.38 6.71 -13.50 0.72 -1.23 5.09
B19 3.83 1.92 4.14 3.10 1.08 2.81 10.41 5.03
B20 12.00 <1.02 1.27 0.28 9.99 1.03 1.69 0.39
B21 10.28 1.00 1.21 0.00 N/A
B22 11.31 1.00 1.62 0.00 N/A
B23 N/A N/A
B25 -2.21 1.00 -6.32 0.00 N/A
B26 11.80 <1.01 1.18 <0.1 9.96 1.02 1.70 0.35
B28 -1.24 -1.33 -10.14 4.08 -4.39 0.32 -3.87 3.50
B30 6.71 1.26 1.87 2.37 4.25 1.55 4.33 2.51
B31 N/A N/A
B33 -5.68 0.87 -1.97 1.65 -9.46 0.92 -1.80 1.48
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Table 1. Continued 
[CD] 5mM 10mM
U (KV) 15 11
Analyte µ α β Rs µ α β Rs
B03 2.45 1.41 4.43 1.88 -1.20 0.29 -7.05 4.62
B04 9.50 1.02 1.25 0.20 6.04 1.04 1.50 0.45
B08 6.46 1.00 2.02 0.00 3.78 1.00 2.47 0.00
B09 -6.14 0.66 -3.06 3.20 N/A
B11 -9.07 0.70 -2.08 3.14 N/A
B13 N/A N/A
B14 -15.76 0.80 -1.25 4.00 N/A
B19 -1.06 -2.71 -16.50 6.16 -3.98 0.46 -10.51 5.10
B20 8.18 1.05 1.70 0.44 4.87 1.10 1.97 0.70
B21 7.70 1.00 2.24 0.00 5.06 1.03 1.86 0.27
B22 8.32 1.00 1.68 0.00 4.50 1.00 1.82 0.00
B23 N/A N/A
B25 -8.17 1.00 -2.39 0.00 -12.20 1.00 -1.05 0.00
B26 8.23 1.04 2.26 0.43 5.33 1.11 1.80 0.98
B28 -7.15 0.59 -2.67 3.35 N/A
B30 2.31 2.06 6.43 2.95 -1.21 -1.25 -8.17 6.77
B31 -4.17 1.00 -4.68 0.00 -6.03 1.00 -2.23 0.00
B33 -12.35 0.94 -1.57 1.43 N/A
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Table 1. Continued 
[CD] 15mM 20mM
U (KV) 11 11
Analyte µ α β Rs µ α β Rs
B03 -4.01 0.79 -3.05 3.51 -5.65 0.85 -2.25 4.38
B30 -3.98 0.41 -3.16 7.83 -5.54 0.55 -2.32 11.22
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Table 1. Continued 
[CD] 0 mM 0.5mM 0.75mM
U (KV) 20 20 20
Analyte µ µ α β Rs µ α β Rs
B34 31.95 23.10 1.00 0.33 0.00 19.02 1.00 0.46 0.00
B37 17.09 5.55 1.37 1.04 1.25 3.07 1.70 2.70 1.48
B38 28.67 13.02 1.00 0.50 0.00 5.80 <1.01 2.31 <0.1
B39 33.85 26.50 1.00 0.25 0.00 23.10 1.00 0.42 0.00
B41 18.05 13.58 1.03 0.42 0.46 11.57 1.06 0.80 0.63
B45 17.09 15.20 1.00 0.41 0.00 14.46 1.00 0.55 0.00
B46 18.49 13.70 1.04 0.78 0.46 11.72 1.08 1.07 1.10
B47 17.56 14.66 1.03 0.39 0.47 13.14 1.07 0.63 1.10
B49 16.72 11.65 1.06 0.36 0.94 9.30 1.11 0.84 1.12
B51 19.10 13.49 1.00 0.32 0.00 11.05 1.00 0.70 0.00
B54 13.45 -1.81 -0.87 -2.65 5.72 -6.02 0.51 -1.35 6.20
B56 31.82 -32.90 1.00 -0.18 0.00 -32.38 1.00 -0.24 0.00
B58 22.21 17.35 1.03 0.24 0.30 14.91 1.09 0.58 0.91
B60 21.70 18.01 1.00 0.57 0.00 16.09 1.03 1.06 0.32
B75 16.61 13.05 1.01 0.31 0.18 11.43 1.03 0.74 0.30
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Table 1. Continued 
[CD] 1.0mM 2.0mM
U (KV) 20 19
Analyte µ α β Rs µ α β Rs
B34 16.52 1.02 0.59 0.25 11.96 1.06 0.76 0.45
B37 N/A -6.73 0.70 -1.72 2.40
B38 N/A -7.18 0.91 -1.66 0.80
B39 20.63 1.00 0.51 0.00 17.21 <1.01 0.51 <0.1
B41 10.02 1.08 1.03 0.73 4.38 1.13 1.74 0.85
B45 13.80 1.00 0.73 0.00 11.58 1.00 0.78 0.00
B46 10.31 1.12 1.01 1.28 6.28 1.25 1.84 1.68
B47 12.13 1.09 0.87 1.11 8.51 1.16 1.14 1.45
B49 7.65 1.15 1.40 1.22 2.42 1.45 5.14 1.81
B51 8.80 1.00 1.21 0.00 1.14 1.00 11.87 0.00
B54 -6.83 0.99 -1.56 <0.05 N/A
B56 -32.04 1.00 -0.33 0.00 N/A
B58 12.64 1.13 0.86 1.06 7.02 1.23 1.48 1.42
B60 14.70 1.05 0.71 0.55 10.93 1.08 1.05 1.03
B75 9.91 1.05 1.08 0.57 5.84 1.10 1.86 1.09
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Table 1. Continued 
[CD] 2.5mM 3.5mM
U (KV) 19 15
Analyte µ α β Rs µ α β Rs
B34 10.45 1.08 1.63 0.78 N/A
B37 -9.40 0.76 -1.91 2.64 -11.91 0.83 -1.51 2.81
B38 -10.04 0.94 -1.79 0.87 -12.52 0.96 -1.35 0.81
B39 16.04 1.01 1.17 0.32 N/A
B41 2.39 1.18 8.05 1.14 N/A
B45 10.76 1.00 1.21 0.00 N/A
B46 4.64 1.36 2.14 1.71 1.77 2.02 10.37 2.45
B47 7.27 1.22 1.78 1.47 N/A
B49 N/A -1.40 0.08 -10.04 3.09
B51 N/A N/A
B54 N/A N/A
B56 -31.10 1.00 -0.49 0.00 N/A
B58 4.80 1.30 2.54 1.46 1.33 2.33 12.73 1.72
B60 9.48 1.10 1.13 1.11 N/A
B75 4.20 1.14 2.89 1.13 1.38 1.61 13.35 1.33
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Table 1. Continued  
[CD] 5mM 10mM
U (KV) 15 11
Analyte µ α β Rs µ α β Rs
B34 6.33 1.22 2.40 1.40 2.46 1.66 3.33 2.66
B37 -13.93 0.86 -1.41 3.01 N/A
B38 N/A N/A
B39 12.68 1.04 1.23 1.16 8.20 1.09 1.84 1.19
B41 -1.88 0.46 -9.39 N/A -4.63 0.80 -1.76 6.69
B45 8.11 1.00 1.96 0.00 5.94 1.02 1.72 0.32
B46 N/A -1.75 0.61 -2.50 5.16
B47 3.41 1.54 4.75 2.98 N/A
B49 -3.76 0.65 -4.98 3.21 N/A
B51 -5.41 1.00 -3.58 0.00 -9.02 1.00 -2.01 0.00
B54 N/A N/A
B56 N/A N/A
B58 N/A -2.74 0.33 -3.23 6.81
B60 4.86 1.26 3.39 1.42 N/A
B75 N/A -2.89 0.73 -2.93 5.44
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In reference to Maynard’s classification of SISCD-mediated separations of 
weakly basic enantiomers,70 four categories of compounds were identified: weakly 
binding, moderately strongly binding, strongly binding and very strongly binding.  
Categorization of the separations in this way provides some insight into the separation 
selectivity patterns observed. It also allows qualitative comparison of the utility of 
HAMS to various SISCDs for a given enantiomer separation. 
For weakly binding analytes, the effective mobilities do not become anionic over 
the HAMS concentration ranged studied.  Figure 47 shows the effective mobilities (top 
panels) and separation selectivities (bottom panels) as a function of the HAMS 
concentration for two weakly binding analytes, terbutaline, B47 and ephedrine, B60. In 
each case, the initial cationic effective mobility of the weak base is 17.5 mobility units 
(B47) and 21.7 mobility units (B60), respectively. As the HAMS concentration is 
increased, their effective mobilities begin to decrease toward zero, but do not become 
anionic. This is due to an increase in the mole fraction of the HAMS-analyte complex 
and to ionic strength-related depression of the effective mobilities of both the free and 
the complexed forms of the weak base. The separation selectivity values increase 
without approaching a limiting value over the HAMS concentration range tested. 
The effective mobilities of moderately strongly binding base analytes are, like 
the weakly binding bases, initially cationic but become anionic at some intermediate 
HAMS concentration. The panels of Figure 48 show the effective mobilities (top panels) 
and the separation selectivities (bottom panels) for two moderately strongly binding 
weak base analytes, aminoglutethimide, B03, and metaproterenol, B30. In both cases,  
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Figure 47. Effective mobilities (top panels) and separation selectivities (bottom panels) 
of weakly binding weak base analytes as a function of HAMS concentration 
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Figure 48. Effective mobilities (top panels) and separation selectivities (bottom panels) 
of moderately strongly binding weak base analytes as a function of HAMS concentration 
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the effective mobilities are cationic at zero and low HAMS concentrations but become 
anionic at an intermediate HAMS concentration ([HAMS]>7.5mM). At HAMS 
concentrations where the effective mobilities of both enantiomers are cationic, 
separation selectivity values are positive and approach infinitely high values as the 
effective mobility of the faster enantiomer approaches zero. As the HAMS concentration 
increases towards an intermediate value, the separation selectivity values become 
negative as the effective mobility of one of the enantiomers becomes anionic and that of 
the other enantiomer remains cationic. At higher HAMS concentrations, the separation 
selectivity values become positive again and approach unity as the effective mobilities of 
both enantiomers remain anionic. Separation selectivities become more favorable as the 
HAMS concentration approaches the point where the effective mobility of one of the 
enantiomers changes from cationic to anionic, as predicted by CHARM model.47 
Strongly binding analytes include those whose effective mobilities have become 
anionic at low HAMS concentrations. Figure 49 shows the effective mobility curves (top 
panels) and the separation selectivity curves (bottom panels) for two strongly binding 
analytes, (1-napthyl)ethylamine, B33 and oxprenolol, B37. Their effective mobilities 
become anionic at HAMS concentrations as low as 1.5 mM and remain anionic over the 
entire concentration range used. Although the separation selectivities follow the trend 
observed for moderately strongly binding analytes, they approach a limiting value of α < 
1 at much lower HAMS concentrations. 
For this discussion, we consider a weak base to be a very strongly binding 
analyte when the effective mobilities of the enantiomers become anionic at a very low 
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HAMS concentration. 4-Chloroamphetamine, B13, and ketotifen, B23, shown in Figure 
50 are examples of weak base analytes that bind very strongly to HAMS.  Their effective 
mobilities (top panels) are anionic at HAMS concentrations lower than 0.6 mM. The 
separation selectivities (bottom panels) follow the classical trends depicted by 
moderately strongly binding and strongly binding weak base analytes. However, their 
separation selectivities approach unity at very low HAMS concentrations (≤ 2.5 mM) 
compared with  strongly binding analytes (≤ 5.0 mM) and moderately strongly binding 
analytes (≤ 20.0 mM). 
The effective mobility and separation selectivity trends so far observed for the 
weak base enantiomers follow the predictions of the CHARM model.47 
Typical electropherograms for the enantiomers of the weak base analytes, 
obtained with HAMS in pH 2.5 BGEs are shown in Figure 51. Each electropherogram 
includes the analyte identifier (see Figure 46), the actual applied potential in kV 
(between the point of injection and the detector) and the HAMS concentration (in mM) 
used for the separation. Baseline resolution was achieved for most of the analytes using 
low concentrations of HAMS. Run time for most of the weak bases was reasonably 
short, except for pindolol, B41 with a time of 23 min.  
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Figure 49. Effective mobilities (top panels) and separation selectivities (bottom panels) 
of strongly binding weak base analytes as a function of HAMS concentration 
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Figure 50. Effective mobilities (top panels) and separation selectivities (bottom panels) 
of very strongly binding weak base analytes as a function of HAMS concentration 
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Figure 51. Typical electropherograms of weak base analytes in pH 2.5 BGE with HAMS 
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Figure 51. Continued 
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Figure 51. Continued 
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3.3.2 Effects of Weak Base Structure on Separation Selectivity 
The binding strength of an enantiomer is highly dependent on its structure and 
the structure of the chiral resolving agent. Small changes in the analytes structure can 
lead to significant changes in the separations. Figure 52 shows the effective mobility 
(top panel) and separation selectivity (bottom panel) curves for four structurally related 
weak bases including B26, B30, B47 and B60. Effective mobilities vary from 8.2 
mobility units for B26 to 2.3 mobility units for B30 at 5 mM HAMS. In order of 
increasing binding strength, they are B30 ≈ B47 > B60 >B26. It is observed that the size 
and the type of substituents about the aromatic ring have some influence on the binding 
strength. The ortho- and meta-catecholamine enantiomers show strong intermolecular 
interaction with HAMS. The weakest binder is metanephrine, B26, with one methyl and 
one OH group on the aromatic ring. The trend observed for the separation selectivities is 
a mirror image of the trend shown by their effective mobilities. Metaproterenol, B30 the 
strongest binding analyte among them exhibits the best separation selectivity while 
separation selectivity is very low for metanephrine, B26, over the concentration range 
tested. These observations, while valid, provide little insight into the enantiorecognition 
mechanism. NMR experiments need to be performed to get mechanistic information. 
Another group of compounds which are structurally related: atropine, B09 and 
homatropine, B19 (shown in Figure 53) differ from each other by a methylene group. 
However, these two compounds show significant difference in their binding strengths 
with HAMS.   
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Figure 52. Effects of analyte structure on effective mobilities (top panel) and separation 
selectivities (bottom panel) for weak bases B26, B30, B47 and B60 obtained in pH 2.5 
BGE using HAMS  
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Figure 53. Effects of analyte structure on effective mobilities (top panel) and separation 
selectivities (bottom panel) for weak bases B09 and B19 obtained in pH 2.5 BGE using 
HAMS 
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3.4 Effects of the Attachment Position of the Sulfate Group on Enantiorecognition  
SISCDs as chiral resolving agents in CE enantioseparations can carry the sulfate 
group either at C2, C3 or C6 positions of the glucopyranose subunits. In order to 
investigate the influence of the position of the sulfate group on enantiorecognition, the 
sodium salt of heptakis(2-O-methyl-3-O-acetyl-6-O-sulfo)cyclomaltoheptaose80 
(HMAS) which carries the sulfate group at the C6 position, and heptakis(2-O-methyl-
3,6-di-O-sulfo)cyclomaltoheptaose81 (HMdiSu) which carries the sulfate group at both 
the C3 and C6 positions are compared to HAMS for the separation of the enantiomers of 
weak bases. These SISCDs, including HAMS, carry non-identical substituents at the C2 
and C3 positions. The changes in the binding strength for homatropine, B19, 
chlophedianol, B14, and metoprolol, B31 are represented in the effective mobility (top 
panel) and separation selectivity (bottom panel) curves shown in Figures 54, 55 and 56, 
respectively. The binding strength for B19 (homatropine) follows the order HMdiSu > 
HAMS > HMAS while for B14 (chlophedianol), the order is HAMS > HMdiSu > 
HMAS. HAMS offers the best separation selectivity (Figures 54 and 55, bottom panel) 
for B19 and B14 at low SISCD concentration where the effective mobilities of the 
enantiomers remain cationic. No separation was observed for the enantiomers of B19 
using HMAS. Interestingly, HAMS does not offer any separation selectivity for the 
enantiomers of B31 over the concentration range studied compared to HMdiSu which 
offered excellent separation selectivity. It is worth noting that although changes in the 
position of the sulfate group on the glucopyranose subunits influence separation 
selectivity, the presence of other substituents including acetyl and methyl groups also 
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play a significant role in the chiral recognition mechanism. X-ray crystallographic and 
NMR spectroscopic measurements are needed for better understanding of the 
enantiorecognition process.   
 
 
Figure 54. Effective mobilities (top panel) and separation selectivites (bottom panel) for 
the enantiomers of B19 in pH 2.5 aqueous BGEs with HAMS, HMdiSu and HMAS 
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Figure 55. Effective mobilities (top panel) and separation selectivites (bottom panel) for 
the enantiomers of B14 in pH 2.5 aqueous BGEs with HAMS, HMdiSu and HMAS 
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Figure 56. Effective mobilities (top panel) and separation selectivites (bottom panel) for 
the enantiomers of B31 in pH 2.5 aqueous BGEs with HAMS, HMdiSu 
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3.5 Separations of the Enantiomers of Nonionic Analytes Using HAMS in Low pH 
BGEs 
According to Williams47, peak resolution values for the enantiomers of nonionic 
analytes are similar at all pH values when SISCDs are used as resolving agents. 
Therefore, it is reasonable to evaluate the utility of HAMS using nonionic analytes at 
low pH. The structures of the fourteen, structurally diverse, nonionic analytes tested are 
shown in Figure 57. Table 2 shows the effective mobilities of the less mobile 
enantiomer, µ, the separation selectivities, α, the calculated peak resolution, Rs, the 
corresponding dimensionless, normalized EOF mobility values, β, and the injector-to-
detector potential drop values, U, obtained in the low pH aqueous BGEs for the 
nonionic enantiomers. An entry of N/A indicates that a value could not be calculated due 
to overlap with either a non-comigrating system peak or overlap with the neutral marker 
peak. 
Enantiomer separations were observed for all of the fourteen nonionic analytes 
tested. All the nonionic analytes were baseline resolved (i.e., Rs > 1.5), except 2-
phenylbutanol, N02. This group of analytes could be assigned to three distinctive 
categories: weakly binding, moderately strongly binding and strongly binding.  
For weakly binding analytes, the effective anionic mobilities (Figure 58, top 
panel) increased as the concentration of HAMS was increased, but remained low, only 
reaching -3.5 × 10-5 cm2/Vs. Increased effective anionic mobility indicates that 
complexation of the nonionic analytes with HAMS overrides the mobility-reducing 
effects of both higher ionic strength and higher viscosity. The corresponding separation  
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Figure 57. Names and structures of nonionic analytes 
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Figure 57. Continued 
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selectivities increased to a maximum and then slowly decreased as the concentration of 
HAMS was increased (Figure 58, bottom panel), in agreement with the prediction of the 
CHARM model.47 
In the case of moderately strongly binding nonionic analytes, their effective 
anionic mobilities (Figure 59, top panel) increased with increasing HAMS concentration 
approaching -10 × 10-5 cm2/Vs. The separation selectivities (Figure 59, bottom panel) for 
this class of nonionic analytes followed the trend depicted by the weakly binding 
analytes. 
Effective anionic mobilities, (Figure 60, top panel) for the strongly binding 
analytes, increased beyond -10 × 10-5 cm2/Vs with increasing HAMS concentration. The 
separation selectivity (Figure 60, bottom panel) patterns resembled those of the 
moderately strongly binding and weakly binding analytes. 
A small change in the structure of the nonionic analytes not only affected 
whether or not a separation was obtained, but it also affected the separation behavior. 
For example, 2-phenylbutanol, N02, 1-phenylbutanol, N21, and 2-phenyl-2-butanol, 
N38 all have the same number of carbon atoms, however, the environments around their 
chiral carbon atoms differ from one to the other. This subtle structural difference still 
leads to significant complexation differences as shown in Figure 61. The order of 
binding strength is N38 > N02 ≈ N21. Interestingly, 1-phenylbutanol, N21 with the 
lowest binding strength exhibits the best separation selectivity (Figure 61, bottom panel). 
In addition to the example describe above, it is also observed that increasing the carbon 
number in the long hydrophobic chain without changing the chiral center can affect the 
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enantiorecogntion processes. Two sets of nonionic analytes which form homologous 
series are depicted in Figures 62 and 63. The first set includes 1-phenylpropanol, N34, 1-
phenylbutanol, N21, and 1-phenylpentanol, N25 (Figure 62). Ethylmandelate, N10, and 
methylmandelate, N15 (Figure 63) constitute the second set. Their effective anionic 
mobilities (top panels) are shown in their respective figures. The order of increasing 
binding strength for the aromatic alcohols is N25 > N21 ≈ N38 and N10 ≈ N15 for the 
mandelates. The separation selectivity (Figures 62 and 63, bottom panels) trends indicate 
that the hydrophobic chain significantly influences the enantiorecogntion process. Again, 
detailed NMR spectroscopic studies are needed to provide insight into the chiral 
recognition mechanism. 
Typical electropherograms for the nonionic analytes obtained by using HAMS as 
chiral resolving agent are shown in Figure 64.  Each electropherogram includes the 
analyte identifier (see Figure 57), the actual applied potential in kV (between the point of 
injection and the detector) and the HAMS concentration (in mM) used for the separation. 
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Table 2.  Separation data for the nonionic analytes in pH 2.5 aqueous HAMS BGE. (µ in 
10-5 cm2/Vs units) 
[CD] 0 mM 0.5mM 0.75mM
U (KV) 20.0 20.0
Analyte µ µ α β Rs µ α β Rs
N02 0.00 -1.61 1.00 -12.07 0.00 -2.18 1.00 -8.53 0.00
N10 0.00 -0.45 1.06 -43.06 0.64 -0.65 1.17 -26.49 1.32
N13 0.00 -1.32 1.00 -15.01 0.00 -1.70 1.00 -10.73 0.00
N15 0.00 -0.55 1.00 -33.42 0.00 -0.72 1.04 -24.14 0.60
N20 0.00 -4.01 1.04 -4.49 0.80 -4.90 1.08 -3.47 0.87
N21 0.00 -1.43 1.09 -13.84 0.77 -2.01 1.18 -8.87 1.31
N22 0.00 -1.95 <1.01 -10.16 <0.1 -2.67 1.05 -6.83 0.34
N25 0.00 -2.78 1.09 -7.15 0.97 -3.55 1.20 -5.15 1.56
N26 0.00 -2.92 1.04 -6.79 0.55 -4.02 1.09 -4.53 1.14
N27 0.00 -1.13 1.00 -15.10 0.00 -1.48 1.07 -13.48 0.53
N28 0.00 -1.30 1.00 -15.20 0.00 -1.76 1.00 -10.58 0.00
N34 0.00 -1.32 1.00 -14.94 0.00 -1.81 1.00 -10.27 0.00
N36 0.00 -0.85 1.00 -22.97 0.00 -1.09 1.04 -16.64 0.60
N38 0.00 -2.12 1.06 -10.10 0.65 -3.13 1.10 -5.65 1.40
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[CD] 1.5mM 2.5mM
U (KV) 20 19
Analyte µ α β Rs µ α β Rs
N02 -3.35 1.04 -6.15 0.36 -4.71 1.08 -3.16 0.63
N10 -1.02 1.40 -17.28 2.22 -1.45 1.46 -9.71 3.57
N13 -2.69 1.08 -7.63 0.44 -3.82 1.10 -3.92 1.40
N15 -1.16 1.16 -21.02 1.16 -1.41 1.25 -11.54 2.52
N20 -6.50 1.21 -3.22 2.32 -7.80 1.26 -2.24 6.45
N21 -3.10 1.29 -6.04 2.03 -4.27 1.34 -2.13 4.22
N22 -4.39 1.10 -4.15 0.87 -6.31 1.14 -1.86 2.26
N25 -4.86 1.29 -3.84 3.22 -6.42 1.31 -2.58 3.98
N26 -6.29 1.19 -2.75 1.85 -9.08 1.19 -2.03 1.97
N27 -2.50 1.16 -7.41 1.35 -3.69 1.18 -4.02 1.80
N28 -2.75 1.04 -7.16 0.45 -3.98 1.08 -3.81 0.73
N34 -2.88 1.08 -6.97 0.45 -4.11 1.11 -3.55 1.33
N36 -1.59 1.18 -12.09 1.44 -2.22 1.30 -4.71 3.71
N38 -5.31 1.20 -3.37 1.49 -7.74 1.19 -2.21 1.63
Table 2. Continued 
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Table 2. Continued 
[CD] 3.5mM 5.0mM
U (KV) 15 15
Analyte µ α β Rs µ α β Rs
N02 -5.92 1.10 -2.31 1.38 -7.16 1.08 -2.01 0.91
N10 -1.84 1.51 -7.99 5.47 -2.31 1.49 -6.58 5.22
N13 -4.88 1.11 -3.05 1.50 -6.21 1.10 -2.60 1.49
N15 -1.73 1.27 -9.66 2.96 -2.02 1.29 -8.05 3.47
N20 -8.70 1.24 -1.82 8.25 -9.67 1.21 -1.49 9.76
N21 -5.45 1.32 -2.07 4.10 -6.97 1.29 -1.65 4.61
N22 -8.02 1.13 -1.91 2.03 -10.17 1.11 -1.74 2.03
N25 -7.78 1.31 -1.73 6.71 -9.54 1.25 -1.57 7.35
N26 -11.44 1.16 -1.59 2.59 -13.81 1.12 -1.31 4.51
N27 -4.79 1.17 -3.13 1.86 -6.17 1.16 -2.37 2.55
N28 -5.11 1.10 -2.91 1.62 -6.57 1.09 -2.44 1.31
N34 -5.28 1.11 -2.80 1.83 -6.76 1.10 -1.97 2.05
N36 -2.78 1.30 -4.19 3.29 -3.38 1.29 -2.48 6.49
N38 -9.87 1.16 -1.81 2.36 -12.11 1.12 -1.31 3.57
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Figure 58. Effective mobilities (top panels) and separation selectivities (bottom panels) 
of weakly binding nonionic analytes as a function of the HAMS concentration 
 
 
 
 
0 1 2 3 4 5
0.5
1.0
1.5
2.0
2.5
0.5
1.0
1.5
2.0
2.5-3
-3.0
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
-3.5
-3.0
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
 
[HAMS]/mM
α
 
µµ µµe
ff /1
0-
5 c
m
2 /V
s
O
O
OH
N10: Ethylmandelate
-5
-4
-3
-2
-1
0
-5
-4
-3
-2
-1
0
0 1 2 3 4 5
0.6
0.8
1.0
1.2
1.4
1.6
1.8
0.6
0.8
1.0
1.2
1.4
1.6
1.8
  
[HAMS]/mM
µµ µµe
ff /1
0-
5 c
m
2 /V
s
  
α
OH
N36:1-Indanol
 124
 
 
 
 
 
 
Figure 59. Effective mobilities (top panels) and separation selectivities (bottom panels) 
of moderately strongly binding nonionic analytes as a function of HAMS concentration 
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Figure 60. Effective mobilities (top panels) and separation selectivities (bottom panels) 
of strongly binding nonionic analytes as a function of the HAMS concentration 
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Figure 61. Effects of analytes structure on effective mobilities (top panel) and separation 
selectivities (bottom panel) for nonionic analytes N02, N21 and N38 obtained in pH 2.5 
BGE using HAMS  
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Figure 62. Effects of the analyte structures on effective mobilities (top panel) and 
separation selectivities (bottom panel) for nonionic analytes N34, N21 and N25 obtained 
in pH 2.5 BGE using HAMS  
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Figure 63. Effects of analyte structure on the effective mobilities (top panel) and 
separation selectivities (bottom panel) for nonionic analytes N10 and N15 obtained in 
pH 2.5 BGE using HAMS 
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Figure 64. Typical electropherograms of nonionic analytes in pH 2.5 BGE with HAMS 
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Figure 64. Continued 
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The changes in the binding strength for some selected nonionic analytes due to 
differences in the functionalization at the C2, C3 and C6 positions are represented in the 
effective mobility (left panel) and separation selectivity (right panel) curves for HAMS, 
HDMS82 (heptakis(2,3-di-O-methyl-6-O-sulfo)cyclomaltoheptaose) and HDAS83 
(heptakis(2,3-di-O-acetyl-6-O-sulfo)cyclomaltoheptaose) shown in Figure 65. HDMS 
and HDAS both carry the sulfate group at the C6 positions. While HDMS carries methyl 
groups at the C2 and C3 positions, HDAS carries acetyl groups at those two positions. 
From the effective mobility values it is observed that the effective anionic mobilities 
increase with increasing SISCDs concentration. Separation selectivity increases to a 
maximum at a low SISCDs concentration and then decreases as SISCDs concentration is 
increased. These trends are in agreement with the predictions of the CHARM model. 
The binding strength of 2-phenyl-2-pentanol, N26, 1-phenylpentanol, N27, and 2-
phenyl-1-propanol, N28 to HAMS (N27 and N28, moderately strongly binding; N26, 
strongly binding) is much higher compared to HDMS (N26, N27 and N28, weakly 
binding). While separation selectivity is higher for N26 and N28 with HAMS as the 
chiral selector compared to HDMS, the opposite is true for N27. HDAS shows similar 
trends in the binding strength of methyl mandelate, N15, 1-phenylpentanol, N27, and 2-
phenyl-1-propanol, N28 compared to HAMS. However, HDAS offers much higher 
separation selectivities for N15 and N28 compared to HAMS. It is very clear that 
different substituents at the C2, C3 and C6 positions of the glucopyranose subunits offer 
different separation selectivities for the same enantiomer pair. However, NMR 
experiments are needed to aid our understanding of the chiral recognition mechanism. 
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Figure 65. Effective mobilities (left panel) and separation selectivities (right panel) of 
N15, N26, N27 and N28 in pH 2.5 aqueous BGE with HAMS, HDMS and HDAS  
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3.6 Separations of the Enantiomers of Strong Electrolyte Analytes Using HAMS in 
Low pH BGEs 
Although HAMS was designed for the separation of nonionic and cationic 
analytes, an attempt was made to separate the enantiomers of six strong electrolyte 
analytes shown in Figure 66. The set of strong electrolyte analytes used includes 
analytes with the sulfate moiety directly attached to the chiral carbon atom and either 
one or two bonds away from the aromatic ring. These analytes were synthesized and 
fully characterized by Nzeadibe.84 The choice of these analytes was based on the 
excellent enantiorecognition observed for the corresponding nonionic aromatic alcohols. 
The results obtained are shown in Table 3. Since the charge of the strong electrolyte 
analyte is independent of the pH of the BGE, detailed studies were carried out in low pH 
BGEs by varying the concentration of HAMS from 0.5 mM to 5.0 mM. As expected, the 
monoanionic analytes have effective mobilities between -23 and -31 × 10-5 cm2/Vs. The 
effective mobilities decreased in the absence of HAMS for the same substitution pattern 
as the length of the alkyl chain was increased; S01 compared to S07 and S02 compared 
to S05, due to the ratio of charge to hydrodynamic volume of the analytes.  
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Upon addition of HAMS to the BGE, the anionic effective mobilities increased to 
a shallow extremum and begin to approach zero as the concentration of HAMS 
increased. The observed decrease in effective anionic mobility could be due to 
increasing ionic strength and viscosity.  The cause of this phenomenon is the interplay 
between the increased mole fraction of the anionic analytes-HAMS complex and the 
increased ionic strength brought about by the increased HAMS concentration. The 
former of these effects increases the contribution of the anionic complex to the effective 
mobility of the band which is greater at low HAMS concentrations, while the latter 
decreases the effective mobility of the anionic complex and its effect is greater at 
relatively high concentrations.70 No separation was observed for the six strong 
electrolyte test analytes, although favorable β values were obtained. This may be due to 
ionic repulsion between the negatively charged analytes and the negatively charged 
chiral resolving agent with the sulfate group located on the chiral face of the SISCD. 
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Figure 66. Names and structures of the strong electrolyte analytes tested 
OSO3
S10: trans-2-Phenyl-1-O-sulfo-cyclohexane
-
OSO3
S07: 1-Pheny-1-O-sulfo-pentane
-
OSO3
S01: 1-Phenyl-1-O-sulfo-propane
-
OSO3
S03: 1-Phenyl-2-O-sulfo-propane
-
O3SO
S02: 2-Phenyl-1-O-sulfo-propane
-
OSO3
S05: 2-Phenyl-1-O-sulfo-butane
-
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 Table 3. Separation data for the strong electrolyte analytes in pH 2.5 aqueous HAMS 
BGE. (µ, in 10-5 cm2/Vs units)   
 
 
 
 
 
[CD] 1.5mM 2.5mM
U (KV) 20.0 19.0
Analyte µ α β Rs µ α β Rs
S01 -34.23 1.00 -0.88 0.00 -34.03 1.00 -0.90 0.00
S02 -35.25 1.00 -0.85 0.00 -34.90 1.00 -0.87 0.00
S03 -34.30 1.00 -0.88 0.00 -33.90 1.00 -0.90 0.00
S05 -29.84 1.00 -1.01 0.00 -29.53 1.00 -1.03 0.00
S07 -28.20 1.00 -1.06 0.00 -27.60 1.00 -1.10 0.00
S10 -30.80 1.00 -0.98 0.00 -30.16 1.00 -1.01 0.00
[CD] 0 mM 0.5mM 0.75mM
U (KV) 20.0 20.0
Analyte µ µ α β Rs µ α β Rs
S01 -30.90 -34.90 1.00 -0.95 0.00 -34.62 1.00 -0.92 0.00
S02 -29.90 -35.95 1.00 -0.91 0.00 -35.63 1.00 -0.89 0.00
S03 -27.50 -35.01 1.00 -0.93 0.00 -34.70 1.00 -0.92 0.00
S05 -25.60 -30.31 1.00 -1.06 0.00 -30.10 1.00 -1.01 0.00
S07 -23.50 -28.90 1.00 -1.14 0.00 -28.70 1.00 -1.11 0.00
S10 -27.40 -31.90 1.00 -1.01 0.00 -31.50 1.00 -1.01 0.00
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Table 3. Continued 
 
 
3.7 Summary 
The first single-isomer β-CD derivative that is sulfated at the C2 position, the 
sodium salt of heptakis(2-O-sulfo-3-O-methyl-6-O-acetyl)cyclomaltoheptaose (HAMS) 
has been used to study the effective mobility and separation selectivity patterns of the 
enantiomers of structurally diverse weak base, nonionic and strong electrolyte analytes 
in acidic aqueous BGEs. The trends observed in all cases followed closely the 
predictions of the CHARM model. HAMS provided effective mobilities and separation 
selectivities that were complimentary to those obtained for the same analytes using other 
sulfated β-CDs.  
 
[CD] 5.0mM
U (KV) 15.0
Analyte µ α β Rs
S01 -33.40 1.00 -0.92 0.00
S02 -34.01 1.00 -0.91 0.00
S03 -33.21 1.00 -0.91 0.00
S05 -28.90 1.00 -1.08 0.00
S07 -26.30 1.00 -1.13 0.00
S10 -29.01 1.00 -1.05 0.00
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CHAPTER IV 
CONCLUSIONS 
 
Several SISCDs have been synthesized and utilized as chiral resolving agents in 
capillary electrophoretic separation of enantiomers including acidic, basic, neutral and 
ampholytic analytes. All these SISCD derivatives carry the sulfate group at either the C3 
or C6 positions of the glucopyranose moieties. Previous work has shown that the cavity 
size of the cyclodextrins and the types of the substituents including acetyl, hydroxyl and 
methyl groups contribute significantly to the enantiorecognition process. However, the 
influence of the attachment position of the sulfate group on the chiral recognition 
capabilities of CDs had not been fully investigated since a SISCD, carrying the sulfate 
group on the C2 position had not yet been synthesized. The need for this investigation to 
be carried out led to the synthesis of the first single-isomer β-CD derivative that is 
sulfated at the C2 position, the sodium salt of heptakis(2-O-sulfo-3-O-methyl-6-O-
acetyl)cyclomaltoheptaose (HAMS). Apart from its potential for enantioresolution of 
both nonionic and ionic chiral analytes, introduction of negative charges on the β-CD 
enhances its solubility in aqueous media. 
The synthetic methodology used to produce HAMS utilized protection and 
deprotection of the 2-, 3- and 6-hydroxyl groups of β-CD by using regioselective 
chemical processes. The first step, which has long been used as a means to bi-
functionalize SISCDs, where the C2 and C3 positions are modified in a “one-pot” 
reaction with either methyl or acetyl groups, involve the protection of the C6 positions 
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with TBDMS. It is worth noting that one of the major steps leading to the successful 
synthesis of HAMS lies in the selective benzylation of the C2 position without 
concurrent modification at the C3 position. A conversion rate of over 80% was achieved 
under 3 hours. Methylation at C3 followed by selective desilylation at C6 gave good 
yields. Subsequent synthetic transformation began with acetylation of the hydroxyl 
group at C6, deprotection at C2 by selective removal of the benzyl group, the second 
major step leading to the successful synthesis of HAMS, and sulfation of the exposed 
hydroxyl groups at C2 to produce HAMS. The acetylation reaction proceeded with 98% 
conversion rate in less than 2 hours. Purification of each intermediate and the final 
product (HAMS) was accomplished using suitable recrystallization solvents and solvent 
mixtures. 
The structural identities of the intermediates and the final product were verified 
by 1D 1H, 13C, 2D COSY and HMQC NMR spectroscopy, and also by high resolution 
MALDI-TOF mass spectrometry.  Non-aqueous, gradient reversed-phase HPLC and 
HILIC-HPLC methods were developed for the determination of the purity of each 
synthetic intermediate and final product. Purities were typically in excess of 97% 
mol/mol. These complementary methods proved that HAMS is pure and has the desired 
structural characteristics of the targeted product. 
HAMS was used to study the effective mobility and separation selectivity trends 
of weak base, nonionic and strong electrolyte analytes. The BGEs were made from a 25 
mM phosphoric acid solution buffered to pH 2.5 with lithium hydroxide. The capillary 
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used was uncoated, bare fused silica and applied potentials were kept within the linear 
region of Ohm’s Law plots. 
Of the thirty-three weakly basic analytes tested, enantiomer separation was 
observed for twenty-seven over the HAMS concentration range used. Eighteen of these 
weak bases were baseline resolved (i.e., Rs > 1.5). In general, four types of separation 
trends were observed for the weak base analytes in the low pH BGEs. (1) For very 
strongly binding analytes, the effective mobilities became anionic at HAMS 
concentrations lower than 0.6 mM. (2) For strongly binding analytes, the effective 
mobilities became anionic at HAMS concentrations as low as 1.5 mM. (3) For the 
moderately strongly binding analytes, the effective mobilities of the analytes became 
anionic at some intermediate HAMS concentration ([HAMS] > 7.5 mM). (4) For weakly 
binding analytes, the effective mobilities did not become anionic over the HAMS 
concentration range tested. The effective mobility and separation selectivity trends for 
the weak bases agreed well with the predictions of the CHARM model. 
Binding strength was found to be highly dependent on the structure of the analyte 
and the resolving agent. A group of structurally similar catecholamines showed that 
changes in substitution about the aromatic ring can result in significant changes in both 
effective mobility and separation selectivity trends. The effective mobilities of the 
analytes at 5 mM spanned from 2.3 to 8.2 10-5 cm2/Vs. Metaproterenol, B30, the 
strongest binding analyte among them exhibits the best separation selectivity. In order to 
investigate the effect of the attachment position of the sulfate group on 
enantiorecognition, the effective mobility and separation selectivity trends observed for 
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homatropine, chlophedianol and metoprolol using HAMS as the chiral resolving agent in 
acidic aqueous BGEs, were compared to those observed with HMAS and HMdiSu. The 
binding strengths of the enantiomers of homatropine were the strongest for HMdiSu and 
decreased in the order HMdiSu > HAMS > HMAS. The binding strengths of the 
enantiomers of chlophedianol were strongest for HAMS and decreased in the order 
HAMS > HMdiSu > HMAS. The binding strength of metoprolol for HAMS was 
stronger compared to HMdiSu. While HMdiSu showed selectivity for all three weak 
base analytes, there was no resolution for homatropine and metoprolol using HMAS 
(homatropine) and HAMS (metoprolol) as chiral selectors. It is worth noting that 
although the position of attachment of the sulfate group significantly influences the 
enantiorecognition process, it is also dependent on the presence of the other substituents, 
including the acetyl and methyl groups. 
Using HAMS for the separation of nonionic analytes, it was found that most 
analytes exhibit one of three specific mobility trends. The first group was called the 
group of weakly binding nonionic analytes: their effective anionic mobilities remained 
low, approaching -4.0 × 10-5 cm2/Vs. The second group was called the group of 
moderately strongly binding analytes: their effective anionic mobilities increased to -
10.0 × 10-5 cm2/Vs. The third group was called the group of strongly binding analytes: 
their effective anionic mobilities increased beyond - 10.0 × 10-5 cm2/Vs.  
The enantiomers of all fourteen nonionic analytes tested using HAMS were 
separated under the experimental conditions used. Experimental results show that 
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separation selectivity depended on (i) the structure of the analyte; and (ii) the polarity of 
the substituents of the β-CD. 
(i) The effect of analytes structure on enantiorecognition is very significant. For 
example, the enantiomers of 2-phenylbutanol, 1-phenylbutanol and 2-phenyl-2-butanol 
showed significantly different separation selectivity behaviors from each other. These 
analytes have the same molecular formula but are different isomers. 1-phenylpropanol, 
1-phenylbutanol and 1-phenylpentanol, which formed a homologous series, showed 
interesting separation selectivity patterns. The same can be said for the enantiomers of 
methylmandelate and ethylmandelate. 
(ii) The type and position of attachment of the different substituents on β-CD led 
to different enantiomer separations. HDMS offered the best separation selectivity values 
for 1-phenyl-2-propanol compared to HDAS and HAMS. On the other hand, HDAS 
offered the best separation selectivity values for 2-phenyl-1-propanol compared with 
HAMS and HDMS. The binding strengths for 1-phenyl-2-propanol and 2-phenyl-1-
propanol decreased in the order HDAS > HAMS > HDMS.  
For the six anionic strong electrolytes, no enantioseparation was observed with 
HAMS over the concentration range studied. This lack of separation may be due to 
repulsion between the analytes and HAMS. 
In conclusion, the first single-isomer, sulfated β-cyclodextrin carrying the sulfo 
group at the C2 position, the sodium salt of heptakis(2-O-sulfo-3-O-methyl-6-O-
acetyl)cyclomaltoheptaose (HAMS) has been produced with isomeric purity greater than 
97% mol/mol. It has been successfully used as a chiral resolving agent for the capillary 
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electrophoretic separations of the enantiomers of weak base and nonionic analytes in 
aqueous acidic BGEs. HAMS proved to be broadly useful and in many cases, had 
separation selectivity complimentary to that obtained with other single isomer sulfated 
cyclodextrins. 
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APPENDIX 
SYNTHESIS PROTOCOL FOR SINGLE-ISOMER HAMS 
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Heptakis(2-O-benzyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose 
1. Dry the pure, heptakis(6-O-t-butyldimethylsilyl)cyclomaltoheptaose (TBDMS7-β-CD) 
in a vacuum oven at 80ºC to remove acetone, DMF and adsorbed water. Note: (i) 
Complete dryness of the material is critical for success of the reaction. (ii) Purity of the 
starting material is essential for the purity of the final product. Oversilylated and 
undersilylated CDs lead to the formation of byproducts that cannot be removed in the 
work-up of the final product.  
2. In a well-ventilated hood, set up on a stir plate an oven-dried 500 ml three-neck round 
bottom flask, equipped with a 1″ Teflon-coated magnetic stir bar, a source of dry N2 gas 
at one neck and, at another neck, an oil bubbler with 1″ of paraffin oil. Connect the oil 
bubbler to the reaction flask through a valve adapter with tabulation. Cap the third neck 
with a ground glass stopper of appropriate size.  Thoroughly purge the set-up with dry 
N2.  
3. Place a clean, dry, flexible Teflon adapter, equipped with a female ground glass joint 
at one end and a male ground joint at the opposing end into an oven at 105ºC. While the 
adapter is being heated, weigh 2.7 g of NaH as 60% dispersion in oil into a 100 ml flask 
specially adapted at the neck to have a male ground glass joint. Next, cap the flask with a 
sealed, female ground glass joint and quickly seal the joint with Parafilm. Note: Do not 
use vacuum grease on any joint. Remove from the oven the flexible adapter that has 
been heating for no longer than 10 minutes. Remove the Parafilm seal from the flask, 
equip it with the flexible adapter and cap. Next, remove the cap from the flexible adapter 
and pour the hydride through the central neck of the reaction flask using female to male 
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ground glass joint adapters if necessary. Once transfer is complete, remove the flexible 
adapter from the reaction flask and quickly cap both the transport vessel and the reaction 
flask. Carefully quench the sodium hydride residue in the transport vessel with ethylene 
glycol. 
4. The oil that coats the sodium hydride must be removed through a series of hexanes 
rinses accomplished using an air-free technique. Rubber septa should be wired down and 
ground glass joints should be equipped with Keck clamps to secure them. Transfer 30 ml 
of dried hexanes from its bottle into a septum-capped 100 ml graduated cyclinder. Next, 
canulate this volume to the reaction flask using a 24″ long, 12-gauge canula. Once the 
hexanes transfer is complete, stir the oily sodium hydride slurry for about 5 minutes, 
then allow sodium hydride to settle. Once sodium hydride has settled, canulate the 
hexanes to an open, 100 ml graduated cylinder by first closing off the oil bubbler. Once 
the first step is complete, repeat the hexanes rinse two more times.  Care must be taken 
not to remove any sodium hydride that may become disturbed during the hexanes 
removal step. Measure 15 ml of dried THF and canulate it into the reaction flask. 
5. In an oven-dried, 250 ml graduated addition funnel, with a standard taper top outer 
joint and lower inner joint, pressure equalizing arm and Teflon stopcock, transfer 60 ml 
of dried THF into the addition funnel. Next, weigh out 25 g of TBDMS7-β-CD and 
transfer into the addition funnel using a polypropylene funnel. Dissolve the solid 
TBDMS7-β-CD by swirling it in the addition funnel. Add 3 ml of dried DMF to the 
addition funnel followed by 1.8 g of TBAI. DMF helps with the dissolution of TBAI. 
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Next, pipette 11.5 ml of benzyl bromide into the addition funnel. Flush the addition 
funnel with dry N2 and attach it to center neck of the 500 ml reaction flask. 
6. While vigorously stirring the sodium hydride/THF slurry, add the solution from the 
addition funnel at the rate of a thin but steady stream over a period of 5-10 min. 
Hydrogen evolution will be observed at the oil bubbler in less than 1-2 minutes. During 
addition, monitor the rate of hydrogen evolution and the degree of foaming in the 
reaction mixture. Foaming should not be so intense that the entire surface of the reaction 
mixture is thickly covered. 30 minutes after addition of the TBDMS7β-CD/TBAI/benzyl 
bromide/THF/DMF solution, take an aliquot of the reaction mixture using a long glass 
pipette with a drawn-out tip. Add two drops of the reaction mixture to a 2 ml glass vial. 
Fill the vial to the neck with HPLC grade methanol. Filter the clear solution through a 
0.45 µm pore-size nylon membrane filter. Analyze the sample by isocratic, non-aqueous 
reversed-phase HPLC at room temperature using a 4.6 mm I.D, 250 mm HPLC column 
packed with 5 µm Luna C18 RP stationary phase and a 55: 45 MeOH : EtOAc mobile 
phase at a flow rate of 2 ml/min. 
7. Once conversion rate reaches about 90 %, quench the reaction by slowly adding 5 ml 
of anhydrous ethanol through a clean addition funnel over a period of 10 to 15 minutes. 
Higher conversion rates lead to overbenzylation, the products of which are difficult to 
remove during work-up. Continue stirring the quenched reaction mixture for another 30 
minutes. 
8. Filter the quenched reaction mixture to remove the precipitated NaI. Rotavap the 
filtrate. Once the crude product begins to precipitate, continue to rotavap until no more 
 154
solvent condenses into the collection vessel. At this point it is safe to increase the 
temperature of the bath to 50ºC to rotavap all of the solvent away. 
9. Add 20 ml of dichloromethane (1.25g/ml) to the crude product. Dissolve the crude 
material and place the flask on a stirrer plate. While stirring, add 380ml of MeOH 
(5%v/v) into the flask. A white precipitate begins to form after about 50% of the total 
volume of MeOH required has been added. Continue stirring for an additional 10 
minutes after methanol addition is completed. Filter the precipitate. Analyze the 
precipitate by isocratic RP-HPLC as in step 6. Typical purity level for the target is > 
99.6%. If purity of the target is lower than expected, repeat step 9. 
 
Heptakis(2-O-benzyl-3-O-methyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose 
1. Dry heptakis(2-O-benzyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose (TBDMS7Bn7-
β-CD) in a vacuum oven at 80ºC to a constant weight.  
2. In a well-ventilated hood, set up on a stir plate an oven-dried 500 ml three-neck round 
bottom flask, equipped with a 1″ Teflon-coated magnetic stir bar, a source of dry N2 gas 
at one neck and, at another neck, an oil bubbler with 1″ of paraffin oil. Connect the oil 
bubbler to the reaction flask through a valve adapter with tabulation. Cap the third neck 
with a ground glass stopper of appropriate size.  Turn on the N2 flow to purge the 500 ml 
flask.  
3. The procedure for transferring NaH into the reaction flask and the removal of oil from 
NaH is the same as described above for the synthesis of heptakis(2-O-benzyl-6-O-t-
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butyldimethylsilyl)cyclomaltoheptaose. Lower the reaction flask into dry paraffin oil 
before proceeding further. 
4. Transfer 60 ml of dried THF into an oven dried, 250 ml graduated addition funnel 
having a standard taper top outer joint, lower inner joint, pressure equalizing arm and 
Teflon stopcock. Next, weigh out 25 g of dry TBDMS7Bn7-β-CD and transfer into the 
addition funnel using a polypropylene funnel. Dissolve the added TBDMS7Bn7-β-CD by 
swirling the addition funnel.  Add 8.5 ml of dried methyl iodide to the addition funnel. 
Flush the addition funnel with dry N2 and attach it to the center neck of the reaction 
flask. Next, place the oil bubbler outlet onto a Liebig condenser and fit the condenser to 
the reaction flask. Equip the Liebig condenser with a recirculating ice water bath. Make 
certain that the oil bath has enough oil to exceed the height of the reaction solvent by a 
full 2″. 
5. While stirring the sodium hydride/THF slurry, slowly begin to add the solution from 
the addition funnel. Bubble formation will begin instantaneously. Monitor the rate of 
hydrogen formation. About 5 minutes into the reaction, turn on the nitrogen flow for 
about 3 minutes, then turn it off again. 
6. Once addition is completed, in about 15 min, stir the reaction mixture for about 2 
hours. Take an aliquot of the reaction mixture using a long glass pipette and add the 
aliquot to a 2 ml glass vial. Add 1 ml of methanol to the vial and spot this solution onto a 
silica TLC plate. Use 2.5 × 10 cm aluminum-backed silica plates and an 8 : 1 mixture of 
hexanes : EtOAc as developing solvent. Once the solvent front migrated close to the top 
of the plate, air dry the plate for 5 minutes and then dip it into the α-naphtol staining 
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solution. Visualize the spots by placing the stained TLC plate into a 90ºC oven for 10 
minutes. 
6. As soon as the TLC plate indicates that the reaction is complete, add 6 ml of 
anhydrous ethanol to a clean addition funnel and begin to carefully drop it into the 
reaction mixture to quench the reaction. 
7. Filter the NaI precipitate out of the reaction mixture. Transfer the filtrate into a round 
bottom flask and rotavap the solvent to obtain the crude product. Digest the crude 
product in 40 ml of dichloromethane and again filter the accumulated NaI precipitate. 
Rotavap dichloroemethane until no more solvent condenses into the collection vessel. 
8. Add 250 ml of ethanol to the crude product in the flask. Place the flask in a heating 
mantle on a stirrer plate. Stir the mixture while warming the flask. Once the crude 
product is completely dissolved, turn off the heating mantle. Do not allow ethanol to 
boil. Slowly begin to add, dropwise, 50 ml of water. Once water addition is complete, 
stir the mixture for 5 minutes. Filter the gooey precipitate. 
9. Analyze the precipitate by isocratic, non-aqueous reversed-phase HPLC at room 
temperature by using a 4.6 mm I.D., 250 mm long HPLC column packed with a 5 µm 
Luna C18 stationary phase, and a 55: 45 mixture of MeOH : EtOAc as the mobile phase, 
at a flow rate of 2 ml/min. The typical purity level for the target is > 99% mol/mol. 
 
Heptakis(2-O-benzyl-3-O-methyl)cyclomaltoheptaose 
1.  Add 120 ml ethanol and 140 ml THF into a 600 ml polyethylene beaker. Add 50 g of 
the pure heptakis(2-O-benzyl-3-O-methyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose 
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to the solvent mixture. Let the cyclodextrin dissolve completely by stirring with 1″ 
Teflon coated magnetic stir bar. Slowly add 70 ml of 48% aqueous HF solution. Cover 
the beaker with aluminum foil and stir the solution for 24 hours. Check completeness of 
the desilylation reaction by TLC using 2.5 × 10 cm Silica 60 plates and a 50 : 10 : 1 
mixture of  CHCl3 : MeOH : H2O as developing solvent. 
2. When the desilylation reaction is complete, take a 10 ml aliquot and place it in a clean 
polyethylene beaker. Prepare a quenching solution by dissolving 60 g of NaOH pellets in 
45 ml of deionized water. Cool the solution to room temperature. Next, add, drop-wise, 
the NaOH solution to 180 ml of ethanol. Place the reaction flask into an ice bath and 
allow it to cool for 30 minutes. Add a small amount of phenolphthalein indicator to the 
cyclodextrin solution. Quench the reaction by slowly adding the sodium hydroxide 
solution to the reaction mixture to neutralize excess HF. Use the aliquot taken in Step 2 
to ensure that the reaction mixture is titrated to the proper endpoint indicted by the 
faintest detectable pink color. 
3.   Once the solution is completely neutralized, filter the NaF precipitate and wash the 
filter cake with ethanol. Rotavap the filtrate to dryness. Redissolve the white solid in 
dichloromethane and filter out the remaining NaF. 
4. Add 50 ml acetone to a 250 ml round bottom flask and add the crude material. Add a 
Teflon-coated stir bar, attach a reflux condenser and reflux the mixture for 10 min. 
Transfer the flask into an ice bath and allow it to cool. Filter the crystals and take a 1H 
NMR spectrum. Repeat Step 4 until the t-butyldimethyl silyl fluoride peaks are no 
longer observed in the 1H NMR spectrum.  
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4. Analyze the precipitate by isocratic, aqueous reversed-phase HPLC at room 
temperature by using a 4.6 mm I.D., 250 mm long HPLC column packed with a 5 µm 
Luna C18 stationary phase and a solvent mixture of 95: 5 MeOH : H2O as mobile phase 
at a flow rate of 2 ml/min. Typical purity level for the target is > 98%. 
 
Heptakis(2-O-benzyl-3-O-methyl-6-O-acetyl)cyclomaltoheptaose 
1. Dry the pure, heptakis(2-O-benzyl-3-O-methyl)cyclomaltoheptaose in a vacuum oven 
at 80ºC to constant weight. 
2. Place a 500 ml, three-neck, round bottom flask with a 1 ″ Teflon coated stir bar and a 
stopper into an oven and dry overnight at 105ºC. Set up the 500 ml three-neck flask on a 
stir plate. Connect a N2 line to one of the side necks on the flask. Connect a condenser to 
the central neck and an oil bubbler with 1″ of paraffin oil to the remaining neck. Place 
the flask into a paraffin oil bath on a stir plate. Flush the system with dry N2 for 
approximately 5 minutes. Replace the N2 line with a stopper. 
3. Open the side neck and with minimum air exposure, add 100 ml of dry pyridine. 
Weigh out 25 g of heptakis(2-O-benzyl-3-O-methyl)cyclomaltoheptaose and transfer 
into the flask via a short-stem plastic funnel. Begin stirring the mixture with the stir bar. 
Once the cyclodextrin has completely dissolved, add 50 ml of acetic anhydride.  
4. Regulate the temperature of the oil bath using a Variac so that the temperature of the 
reaction mixture is between 50ºC - 55ºC. Continue stirring for 30 minutes. 
5. Take an aliquot of the reaction mixture using a long glass pipette with a drawn-out tip. 
Add two drops of the reaction mixture to a 2 ml glass vial. Fill the vial to the neck with 
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HPLC grade methanol. Filter the solution through a 0.45 µm pore-size nylon membrane 
filter. Analyze the sample by isocratic, aqueous reversed-phase HPLC at room 
temperature by using a 4.6 mm I.D., 250 mm long HPLC column packed with a 5 µm 
Luna C18 as stationary phase and a mixture of 95: 5 MeOH : H2O as mobile phase at a 
flow rate of 2 ml/min. 
6. Once the reaction is complete, replace the oil bath with a cork ring. While stirring, 
open the side neck and add 25 ml of ethanol that will consume the excess acetic 
anhydride. Rotovap the reaction solvent and acetic acid by-products until no more 
solvent distils over. 
7. Redissolve the crude product in 450 dichloromethane. Into a 5 L round bottom flask 
add 3.5 L of hexanes and a Teflon-coated  magnetic stirrer. Place the flask in a cork-ring 
on a stir plate. While stirring the hexanes solvent slowly add the concentrated 
cyclodextrin – dichloromethane solution. Upon complete addition, allow the mixture to 
stand for 10 minutes and filter the precipitate. 
8. Check the purity of the product by isocratic, aqueous reversed-phase HPLC, at room 
temperature, by using a 4.6 mm I.D., 250 mm long HPLC column packed with a 5 µm 
Luna C18 RP stationary phase, and a 95: 5 mixture of  MeOH : H2O as the mobile 
phase, at a flow rate of 2 ml/min. Typical purity level for the target is > 99%. 
 
Heptakis(3-O-methyl-6-O-acetyl)cyclomaltoheptaose 
1. Dry the pure heptakis(2-O-benzyl-3-O-methyl-6-O-acetyl)cyclomaltoheptaose in a 
vacuum oven at 60ºC to constant weight. 
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2. Place a 250 ml, three-neck, round bottom flask with a 1″ Teflon coated stir bar and a 
stopper into an oven and dry overnight at 110ºC. Set up the 250 ml three-neck flask on a 
stir plate. Connect a N2 line to one of the side necks on the flask and at another neck, an 
oil bubbler with 1″ of paraffin oil. Cap the third neck with a ground glass stopper of 
appropriate size. Flush the system with dry N2 for approximately 5 minutes. Replace the 
N2 line with a stopper. 
3. Obtain a 10 ml syringe and a needle. Dispose the plunger and cut the finger flanges of 
the hollow barrel. Insert the cut end of the hollow barrel into a balloon and secure the 
balloon unto the barrel over Teflon tape. Next, insert the needle into a septum. Fill the 
balloon with hydrogen and as quickly as possible, fit the female luer-lock connector of 
the needle to the male luer-lock tip of the hollow barrel. 
4. Add 50 ml of anhydrous MeOH and 50 ml of anhydrous dioxane into the reaction 
flask. With minimum exposure, transfer 20 g of heptakis(2-O-benzyl-3-O-methyl-6-O-
acetyl)cyclomaltoheptaose into the flask using a short-stem plastic funnel. While stirring 
to dissolve the cyclodextrin, flush the system with N2 for 5 minutes. Weigh out 7 g of 10 
% Pd on activated charcoal and quickly transfer it into the reaction flask. Disconnect the 
N2 line and insert the needle at the end of the hydrogen-filled balloon into the septum. 
Allow the hydrogen to flush the system for 5 minutes, then disconnect the oil bubbler 
line. Note: Efficiency of this reaction is highly dependent on the quality of the catalyst. 
5. With a 1 ml syringe and a needle, draw out 0.3 ml of the reaction mixture. Release the 
0.3 ml reaction mixture into a 2 ml glass vial. Fill the vial to the neck with ACN. Next, 
filter the solution through a 0.45 µm pore-size nylon membrane filter. Analyze the 
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sample by reversed-phase HPLC using a 4.6 mm I.D., 250 mm long HPLC column 
packed with a 5 µm Luna C18 RP stationary phase, and gradient elution at a flow rate of 
1 ml/min. The initial mobile phase compostion is 80 : 20 H2O : ACN that changes to 2 : 
98 H2O : ACN in 15 minutes, at 40ºC. The reaction time is between 22 – 24 hours. 
6. Upon completion of the reaction, filter the catalyst and remove the reaction solvent 
under reduced pressure. 
7. Redissolve the crude product in 200 ml dichloromethane. Into a 3 L round bottom 
flask add 1.5 L of hexanes and a Teflon-coated magnetic stirrer. Place the flask in a 
cork-ring on a stir plate. While stirring the hexanes solvent, slowly add (dropwise) the 
concentrated cyclodextrin–containing dichloromethane solution. Upon complete 
addition, allow the mixture to stand for 10 minutes and filter the precipitate. 
8. Analyse the precipitate by the HPLC method described in step 5. Typical purity level 
for the target is > 98%. 
 
Heptakis(2-O-sulfo-3-O-methyl-6-O-acetyl)cyclomaltoheptaose 
1. Place heptakis(3-O-methyl-6-O-acetyl)cyclomaltoheptaose in a crystallizing dish and 
dry it in a vacuum oven at 60ºC to constant weight. 
2. Place a 250 ml, three-neck, round bottom flask with a 1″ Teflon-coated stir bar and a 
stopper into an oven and dry overnight at 110ºC. Set up the 250 ml three-neck flask on a 
stir plate. Connect a N2 line to one of the side necks on the flask. Connect a condenser to 
the central neck and to remaining neck, an oil bubbler with 1″ of paraffin oil. Place the 
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flask into a paraffin oil bath on a stir plate. Flush the system with dry N2 for 
approximately 5 minutes. Replace the N2 line with a stopper. 
3. Open the side neck and with minimum air exposure, add 50 ml of dry pyridine and 35 
ml of DMF to the flask. Close the system with the stopper. Weigh out 10 g of 
heptakis(3-O-methyl-6-O-acetyl)cyclomaltoheptaose and transfer it into the flask via a 
short-stem plastic funnel. Begin stirring with the stir bar. Continue stirring until a clear 
solution is obtained. Quickly weigh out 16 g of Py.SO3 and immediately transfer into 
the flask via a plastic funnel. Replace the stopper.  
4. Regulate the temperature of the oil bath using a Variac so that the temperature of the 
reaction mixture is around 40ºC. Continue stirring for 2 hours. 
5. Monitor the progress of the reaction by HPLC using a 4.6 mm I.D., 150 mm long 
column packed with a 3µm Luna HILIC stationary phase. Use gradient elution at a flow 
rate of 1 ml/min. The initial mobile phase composition is 100% A that changes to 50% A 
: 50% B in 30 min ( A: 5 mM HCOONH4 in 95% ACN, B: 5mM HCOONH4 in H2O) at 
room temperature.  
6. Once the reaction is complete, prepare a slurry of 23 g NaHCO3 in 30 ml water. Place 
the reaction flask in an ice bath on a stir plate and begin vigorous stirring. Slowly add 
the slurry in portions, waiting until there is no more bubble formation (CO2) between 
additions. Be careful not to lose solution because of excessive foaming. After half the 
slurry has been added, begin checking the pH prior to the addition of each subsequent 
portion. Stop the addition of the slurry when the strip of the pH paper turns green. Filter 
off the solids. 
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7. Transfer the filtrate to a 1L round bottom flask with a 1″ Teflon-coated stir bar and 
rotavap the solution to dryness in a high vacuum rotavap at 50ºC. 
8. Dissolve the solids in 100 ml MeOH. Into a 1 L round bottom flask add 725 ml of 
diethyl ether and a Teflon-coated magnetic stirrer. Place the flask in a cork-ring on a stir 
plate. While stirring the diethyl ether solvent, slowly add the concentrated cyclodextrin - 
MeOH solution. A precipitate will form. Filter and obtain the precipitate. Check its 
purity by HPLC (Step 5). Check the removal of DMF by 1H NMR. If needed, repeat 
Step 8. 
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